AU2014262192A1 - Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide - Google Patents

Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide Download PDF

Info

Publication number
AU2014262192A1
AU2014262192A1 AU2014262192A AU2014262192A AU2014262192A1 AU 2014262192 A1 AU2014262192 A1 AU 2014262192A1 AU 2014262192 A AU2014262192 A AU 2014262192A AU 2014262192 A AU2014262192 A AU 2014262192A AU 2014262192 A1 AU2014262192 A1 AU 2014262192A1
Authority
AU
Australia
Prior art keywords
compound
solid
spp
animal
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014262192A
Inventor
Martin James Currie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011258621A external-priority patent/AU2011258621B2/en
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Priority to AU2014262192A priority Critical patent/AU2014262192A1/en
Publication of AU2014262192A1 publication Critical patent/AU2014262192A1/en
Abandoned legal-status Critical Current

Links

Abstract

Disclosed is a solid form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5 (trifluoromethyl)-3 -isoxazolyl] -N- [2-oxo-2- [(2,2,2-trifluoroethyl)amino] ethyl] -1 naphthalenecarboxamide (Compound 1). 5 Also disclosed are compositions containing a solid form of Compound 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a solid form of Compound 1 or a composition containing a solid form of Compound 1. U- 01 C) 0e '7 I- C-, C) f~isue-0

Description

P/00/011 Regulation 3.2 AUSTRALIA Patents Act 1990 COMPLETE SPECIFICATION FOR A DIVISIONAL PATENT ORIGINAL Name of Applicant: E. I. DU PONT DE NEMOURS AND COMPANY Actual Inventor: Martin James CURRIE Address for Service: Houlihan 2 , Level 1, 70 Doncaster Road, Balwyn North, Victoria 3104, Australia Invention Title: CRYSTALLINE FORM OF 4-[5-[3-CHLORO-5 (TRIFLUOROMETHYL)PHENYL]-4,5-DIHYDRO-5 (TRIFLUOROMETHYL)-3-ISOXAZOLYL]-N-[2-OXO-2 [(2,2,2-TRIFLUOROETHYL)AMINO]ETHYL] -1 NAPHTHALENECARBOXAMIDE The following statement is a full description of this invention, including the best method of performing it known to the Applicant: 1 2 TITLE CRYSTALLINE FORM OF 4-[5-[3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL]-4,5 DIHYDRO-5-(TRIFLUOROMETHYL)-3-ISOXAZOLYL]-N-[2-OXO-2-[(2,2,2 TRIFLUOROETHYL)AMINO] ETHYL] -1 -NAPHTHALENECARB OXAMIDE 5 The present application is a divisional application from Australian patent application number 2011258621. The entire disclosures of Australian patent application number 2011258621 and its corresponding International application, PCT/US2011/037083, are incorporated herein by reference. 10 FIELD OF THE INVENTION This invention relates to a solid form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5 dihydro-5 -(trifluoromethyl)-3 -isoxazolyl] -N- [2-oxo-2- [(2,2,2-trifluoroethyl)amino] ethyl] -1 naphthalenecarboxamide. BACKGROUND OF THE INVENTION 15 The solid state of chemical compounds can be amorphous (i.e. no long-range order in the positions of atoms) or crystalline (i.e. atoms arranged in an orderly repeating pattern). While only one crystal form is known for the solid state of many compounds, polymorphs have been discovered for some compounds. The term "polymorph" refers to a particular crystal form (i.e. structure of crystal lattice) of a chemical compound that can exist in more 20 than one crystal form in the solid state. Polymorphs can differ in such chemical and physical (i.e. physiochemical) properties as crystal shape, density, hardness, color, chemical stability, melting point, hydroscopicity, suspensibility and dissolution rate, and such biological properties as biological availability. Predicting physiochemical properties such as melting point for a crystal form or crystal 25 forms in which the solid state of a chemical compound can exist remains impossible. Furthermore, even predicting whether the solid state of a compound may be present in more than one crystal form is not possible. PCT Patent Publication WO 09/002809 discloses 4-[5-[3-chloro-5 (trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2 30 trifluoroethyl)amino] ethyl] -1 -naphthalenecarboxamide and methods for its preparation, as well as the utility of this compound as an invertebrate pest control agent. A new solid form of this compound has now been discovered. SUMMARY OF THE INVENTION This invention relates to a solid form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5 35 dihydro-5 -(trifluoromethyl)-3 -isoxazolyl] -N- [2-oxo-2- [(2,2,2-trifluoroethyl)amino] ethyl] -1- 3 naphthalenecarboxamide (Compound 1). More particularly, this invention is directed to a crystalline polymorph of Compound 1 designated Form B characterized by a powder X-ray diffraction pattern having at least the 2 reflection positions 17.433, 18.586, 20.207, 20.791, 21.41, 22.112, 23.182, 24.567 and 27.844. 5 This invention also relates to compositions containing a solid form of Compound 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a solid form of Compound 1 or a composition containing a solid form of Compound 1. BRIEF DESCRIPTION OF THE DRAWINGS 10 FIGURE 1 is the powder X-ray diffraction patterns of polymorph and pseudopolymorph crystal forms of Compound 1 showing absolute intensity count graphed against 2 reflection positions. DETAILED DESCRIPTION OF THE INVENTION As used herein, the terms "comprises," "comprising," "includes," "including," "has," 15 "having", "contains" or "containing" or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus. Further, unless expressly stated to the contrary, "or" refers to an 20 inclusive or and not to an exclusive or. For example, a condition A or B is satisfied by any one of the following: A is true (or present) and B is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true (or present). Also, the indefinite articles "a" and "an" preceding an element or component of the invention are intended to be nonrestrictive regarding the number of instances (i.e. 25 occurrences) of the element or component. Therefore "a" or "an" should be read to include one or at least one, and the singular word form of the element or component also includes the plural unless the number is obviously meant to be singular. Embodiments of the present invention include: 30 Embodiment 1. The crystalline solid form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl] 4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2 trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide wherein at least 90% of the solid form is polymorph Form B. Embodiment 2. The crystalline solid form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl] 35 4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2 trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide wherein at least 80% of the solid form is polymorph Form B.
4 Embodiment 3. The crystalline solid form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl] 4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2 trifluoroethyl)amino] ethyl] -1 -naphthalenecarboxamide wherein at least 70% of the solid form is polymorph Form B. 5 Embodiment 4. The crystalline solid form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl] 4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2 trifluoroethyl)amino] ethyl] -1 -naphthalenecarboxamide wherein at least 60% of the solid form is polymorph Form B. Embodiment 5. A composition comprising Compound 1, wherein Compound 1 is 10 present in at least 90% polymorph Form B, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising at least one additional biologically active compound or agent. Embodiment 6. A composition comprising Compound 1, wherein Compound 1 is 15 present in at least 80% polymorph Form B, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising at least one additional biologically active compound or agent. Embodiment 7. A composition comprising Compound 1, wherein Compound 1 is 20 present in at least 70% polymorph Form B, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising at least one additional biologically active compound or agent. Embodiment 8. A composition comprising Compound 1, wherein Compound 1 is 25 present in at least 60% polymorph Form B, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising at least one additional biologically active compound or agent. The crystalline polymorph of Compound 1 designated Form B, and any embodiments 30 of the invention can be used for the protection of an animal from an invertebrate pest by administration of the compound to the animal. Therefore, the invention is understood to include the crystalline polymorph of Compound 1 designated Form B, or any embodiments of the invention for use as an animal medicament, or more particularly a parasiticidal animal medicament. The medicament may 35 be in any art recognized dosage forms including oral, topical or parenteral dosage forms. The invention is also understood to include the use of the crystalline polymorph of Compound 1 designated Form B, or any embodiments of the invention for the manufacture of a medicament for the protection of an animal from an invertebrate pest. The medicament 5 may be in any art recognized dosage forms including oral, topical or parenteral dosage forms. The invention is also understood to include the crystalline polymorph of Compound 1 designated Form B, or any embodiments of the invention, packaged and presented for the 5 protection of an animal from an invertebrate pest. The compounds of the invention may be packaged and presented as oral, topical or parenteral dosage forms. The invention is also understood to include a process for manufacturing a composition for protecting an animal from an invertebrate parasitic pest characterized in that the crystalline polymorph of Compound 1 designated Form B, or any embodiments of the 10 invention, are admixed with at least one carrier. The compounds of the invention may be packaged and presented in any art recognized dosage forms including oral, topical or parenteral dosage forms. Compound 1 is 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5 15 (trifluoromethyl)-3 -isoxazolyl] -N- [2-oxo-2- [(2,2,2-trifluoroethyl)amino] ethyl] -1 naphthalenecarboxamide and has the following chemical structure: CF3C ON Cl H O N ' N " C F 3 CF3 1 Compound 1 can exist in more than one crystal form (i.e. polymorph). One skilled in 20 the art will appreciate that a polymorph of Compound 1 can exhibit beneficial effects (e.g., suitability for preparation of useful formulations, improved biological performance) relative to another polymorph or a mixture of polymorphs of the same Compound 1. Differences with respect to chemical stability, filterability, solubility, hygroscopicity, melting point, solid density and flowability can have a significant effect on the development of production 25 methods and formulations, and the quality and efficacy of plant treatment agents. The molecular structure of Compound 1 can exist as two distinct stereoisomers (i.e. enantiomers). The present invention encompasses a racemic mixture of Compound 1 comprising equal amounts of the two possible enantiomers. The solid state of Compound 1 has now been discovered to be preparable in more than 30 one solid form. These solid forms include an amorphous solid form, in which there is no long-range order in the positions of molecules (e.g., foams and glasses). These solid forms 6 also include crystalline forms, in which constituent molecules are arranged in an orderly repeating pattern extending in all three spatial dimensions. The term "polymorph" refers to a particular crystalline form of a chemical compound that can exist in more than one crystal structure (e.g., lattice type) in the solid state. Crystalline forms of Compound 1 in this 5 invention relate to embodiments which include a single polymorph (i.e. single crystalline form) and to embodiments which include a mixture of polymorphs (i.e. different crystalline forms). Polymorphs can differ in such chemical, physical and biological properties as crystal shape, density, hardness, color, chemical stability, melting point, hygroscopicity, suspensibility, dissolution rate and biological availability. One skilled in the art will 10 appreciate that a polymorph of Compound 1 can exhibit beneficial effects (e.g., suitability for preparation of useful formulations, improved biological performance) relative to another polymorph or a mixture of polymorphs of Compound 1. Differences with respect to chemical stability, filterability, solubility, hygroscopicity, melting point, solid density and flowability can have a significant effect on the development of production methods and 15 formulations, and the quality and efficacy of plant treatment agents. Preparation and isolation of particular polymorphs of Compound 1 has now been achieved. Most of the polymorphs of Compound 1 are pseudopolymorphs (different crystal types that are a result of hydration or solvation). A solvate is a crystal form with either a stoichiometric or non-stoichiometric amount of solvent. A hydrate is a solvate with water as 20 the solvent. A variety of experimental procedures were conducted to explore the crystalline solid profile for Compound 1. Crystalline solids with eight unique X-ray powder diffraction patterns (XRPD) as well as X-ray amorphous material were generated. The XRPD patterns for the various solids are shown in Figure 1. Most of the solids are solvates or hydrates. 25 Solids known to be composed of a single phase are designated as 'Form X' and solids labeled 'Pattern X' may represent a mixture of solid forms. Two polymorphs were identified (Form A and Form B). The crystalline solid profile experiments can be summarized as shown in Scheme 1.
7 Scheme 1 Pattern C EtOAc solvate Pattern D Form B dioxane solvate hydrate EtOAc dioxane MeOH/H 2 0 iPrOH ml Pattern E : Form A melt X-ray quench amorphous nPrOH iPrOH/H 2 0
ACN/H
2 0 vacuum dry\ Pattern F Pattern H nPrOH solvate iPrOH solvate Pattern G ACN solvate Compound 1 can exist as an amorphous solid. The XRPD pattern for amorphous solid Compound 1 shows no significant signals and thus is readily distinguished from the patterns 5 of crystalline Compound 1. The amorphous form of Compound 1 can also be characterized by cyclic Differential Scanning Calorimetry. As described in Characterization Example 2 the glass transition temperature of an amorphous form of Compound 1 was determined to be about 72 'C. The amorphous form of Compound 1 is physically unstable and readily crystallized in its pure 10 solid form (shown in Characterization Example 3). The amorphous solid form was prepared by melting polymorph Form A and then quickly quenching in a dry ice/acetone bath. One crystalline polymorph form of Compound 1 is designated as Form A. This solid form is a desolvated solvate. A desolvated solvate is formed from a solvate crystal form 15 (containing Compound 1 and solvent molecules) losing the solvent molecules via channels in the crystal under vacuum and heating conditions resulting in a desolvated crystal form with the same molecular packing as the parent solvate crystal form. Form A can be characterized by X-Ray powder diffraction (XRPD) and Differential Scanning Calorimetry (DSC). The powder X-ray diffraction pattern of polymorph Form A of Compound 1 is shown 20 in Figure 1. The corresponding 2 values are tabulated in Table 1 of Characterization Example 1. Polymorph Form A of Compound 1 can be identified by a powder X-ray diffraction pattern having at least the 2 reflection positions 8 2 16.196 19.389 20.324 21.494 22.263 22.797 23.766 25.672 27.492 Polymorph Form A of Compound 1 can also be characterized by Differential Scanning Calorimetry. DSC indicates the melting point of polymorph Form A is about 113 'C. The details of a DSC experiment are provided in Characterization Example 2. Polymorph Form 5 A is non-hygroscopic and a desolvated solvate related to Pattern G solid which is the acetonitrile solvate of Form A (shown in Characterization Example 3 and 5). Polymorph Form A of Compound 1 can be prepared by the procedure described in PCT Patent Publication WO 09/025983 (for example, see Synthesis Example 7). Recrystallization of the crude solid product from acetonitrile usually yields a mixture of 10 Pattern G solid and Form A of Compound 1. Conversion of the mixed solvate/desolvate recrystallized product to Form A can be achieved by vacuum drying (50 'C, 4-24 hours). A second crystalline polymorph form of Compound 1 is designated as Form B. This solid form is a hydrate. The powder X-ray diffraction pattern of polymorph Form B of Compound 1 is shown 15 in Figure 1. The corresponding 2 values are tabulated in Table 2 of Characterization Example 1. Polymorph Form B of Compound 1 can be identified by a powder X-ray diffraction pattern having at least the 2 reflection positions 2 17.433 18.586 20.207 20.791 21.41 22.112 23.182 24.567 27.844 9 Polymorph Form B of Compound 1 can also be characterized by Differential Scanning Calorimetry. DSC indicates the melting point of polymorph Form B is about 147 'C. The details of a DSC experiment are provided in Characterization Example 2. Polymorph Form 5 B is physically stable and hydrated in its pure solid form (shown in Characterization Example 3). The higher melting point of polymorph Form B is advantageous for use in formulations that involve milling of the active ingredient or a slurry of the active ingredient in liquid carriers. Slow recrystallization of Form A from methanol/water provided a first purified crop of 10 Form B crystals as described in Preparation Example 1. Polymorph Form B was also produced by slurring polymorph Form A in methanol/water (1:2) at 60 'C for 3 days and then cooling to 22 'C and filtration. Efficient large-scale preparation of Form B is facilitated by the addition of the previously prepared Form B seed crystals to the solution of Compound 1 in methanol/water to cause the product to crystallize in polymorph Form B (see 15 Preparation Examples 2 and 3). The relative stability of polymorphic Forms A and B of Compound 1 was characterized with interconversion slurry experiments (see Characterization Example 4). The relative physical stability of Compound 1 solid forms is dependent on the solvent used in the slurry experiment. Pattern G solid is the most stable solid form in acetonitrile. 20 Polymorph Form A is a metastable solid form with respect to Pattern G solid in acetonitrile and is sometimes formed in a mixture with Pattern G solid from acetonitrile. Pattern G solid can be converted to polymorph Form A by desolvation via vacuum drying. Polymorph Form B is the most stable solid form in organic solvent/water mixtures especially in methanol/water. 25 Another crystalline solid form of Compound 1 was designated Pattern C solid. Pattern C solid was characterized by X-Ray powder diffraction and Differential Scanning Calorimetry. The powder X-ray diffraction pattern of Pattern C of Compound 1 is shown in Figure 1. By DSC Pattern C solid exhibited a single endotherm at 101 'C accompanied by a 9.4% weight loss. Ethyl acetate was detected in the 1 H NMR of the material indicating that 30 the solid is an ethyl acetate solvate. Pattern C solid was prepared by dissolving Compound 1 in ethyl acetate at 80 'C and then slow cooling to 22 'C and filtration. Another crystalline solid form of Compound 1 was designated Pattern D solid. Pattern D solid was characterized by X-Ray powder diffraction and Differential Scanning Calorimetry. The powder X-ray diffraction pattern of Pattern D of Compound 1 is shown in 35 Figure 1. By DSC Pattern D solid exhibited a single endotherm at 105 'C accompanied by a 5.1% weight loss. Dioxane was detected in the 1 H NMR of the material indicating that the solid is a dioxane solvate. Pattern D solid was prepared by dissolving Compound 1 in dioxane and then fast evaporation under a stream of nitrogen gas at 22 'C.
10 Another crystalline solid form of Compound 1 was designated Pattern E solid. Pattern E solid was characterized only by X-Ray powder diffraction (Figure 1). Pattern E solid was prepared by dissolving Compound 1 in isopropyl alcohol and then fast evaporation under a stream of nitrogen gas at 22 'C. 5 Another crystalline solid form of Compound 1 was designated Pattern F solid. Pattern F solid was characterized by X-Ray powder diffraction and Differential Scanning Calorimetry. The powder X-ray diffraction pattern of Pattern F of Compound 1 is shown in Figure 1. By DSC Pattern F solid exhibited a single endotherm at 87 'C accompanied by a 10% weight loss. 1-Propanol was detected in the 1 H NMR of the material indicating that the 10 solid is a 1-propanol solvate. Pattern F solid was prepared by slurring Compound 1 in 1 propanol/water (9:1) at 40 'C for 4 days and then cooling to 22 'C and filtration. Another crystalline solid form of Compound 1 was designated Pattern G solid. Pattern G solid was characterized by X-Ray powder diffraction and Differential Scanning Calorimetry. The powder X-ray diffraction pattern of Pattern G of Compound 1 is shown in 15 Figure 1. By DSC Pattern G solid exhibited a single endotherm at 73 'C accompanied by a 7% weight loss. Acetonitrile was detected in the 1 H NMR of the material indicating that the solid is an acetonitrile solvate. Pattern G solid was prepared by slurring Compound 1 in acetonitrile/water (1:1) at 40 'C and then slow cooling to 22 'C and filtration. Pattern G solid was consistently prepared from acetonitrile under a variety of recrystallization 20 conditions. Another crystalline solid form of Compound 1 was designated Pattern H solid. Pattern H solid was characterized by X-Ray powder diffraction and Differential Scanning Calorimetry. The powder X-ray diffraction pattern of Pattern H of Compound 1 is shown in Figure 1. By DSC Pattern H solid exhibited a single endotherm at 97 'C accompanied by a 25 3.5% weight loss. Iso-propanol was detected in the 1 H NMR of the material indicating that the solid is a iso-propanol solvate. Pattern H solid was prepared by slurring Compound 1 in iso-propanol/water (1:1) at 40 'C for 4 days and then cooling to 22 'C and filtration. CHARACTERIZATION EXAMPLE 1 30 X-Ray Powder Diffraction Experiments Powder X-ray diffraction was used to identify the crystallized phases of Compound 1. X-ray Powder Diffraction (XRPD) analysis were preformed using an Inel XRG-3000 diffractometer equipped with a CPS (Curved Position Sensitive) detector with a 2 range of 1200. Slits used were 5 mm by 160 pm. 35 XRPD analysis were also performed using a Shimadzu XRD-6000 with Cu (K ) radiation.
11 The radiation was Cu (K ), 40 kV, 30 mA. Samples were packed powders in an spinning capillary. Data were collected at 2 angles with an equivalent step size of 0.03 degrees and acquisition time was 300 seconds. Table 1 5 2 X-ray maxima for Polymorph A of Compound 1 2 2 2 2 2 2 7.937 18.804 24.97 32.824 40.012 49.287 11.233 19.389 25.672 33.443 41.447 50.022 13.021 20.324 27.492 34.197 43.486 75.486 13.707 21.494 28.262 34.963 44.001 14.574 22.263 29.586 36.598 44.675 16.196 22.797 30.335 37.908 45.726 16.797 23.766 30.969 38.338 47.079 17.203 24.218 31.955 39.073 48.453 Table 2 2 X-ray maxima for Polymorph B of Compound 1 2 2 2 2 2 2 9.393 17.433 23.182 28.828 39.273 48.635 11.117 18.586 24.567 29.967 40.593 50.172 12.452 20.207 25.103 32.39 42.034 59.533 14.023 20.791 25.853 34.83 43.237 14.744 21.41 26.942 36.301 44.906 15.361 22.112 27.844 37.286 47.078 CHARACTERIZATION EXAMPLE 2 Differential Scanning Calorimetry Experiments 10 Differential scanning calorimetry was performed on a Thermal Analysis Q2000 Differential Scanning Calorimeter. A sample was placed in an aluminum DSC pan and the weight accurately recorded. The sample cell was equilibrated at 25 'C or -30 'C and heated under a nitrogen purge at a rate of 10 'C/minute up to a final temperature of 250 'C. Indium metal was used as the calibration standard. 15 A cyclic DSC experiment was also preformed using a Thermal Analysis Q2000 Differential Scanning Calorimeter. A sample was placed in an aluminum DSC pan and the weight accurately recorded. The sample cell was equilibrated at 25 'C and heated under a nitrogen purge at a rate of 10 'C/minute up to a final temperature of 140 'C, rapidly cooled to -40 'C and reheated to a final temperature of 250 'C. Indium metal was used as the 20 calibration standard. The glass transition temperature (Tg) of amorphous Compound 1 was determined to be 72 'C at half-height.
12 The DSC curve for polymorph Form A of Compound 1 was observed to exhibit a sharp endotherm at 113 'C. The DSC curve for polymorph Form B of Compound 1 was observed to exhibit a sharp endotherm at 147 'C. 5 CHARACTERIZATION EXAMPLE 3 Stability Experiments for Solid Forms of Compound 1 The physical stability of the amorphous material was characterized. Amorphous Compound 1 was vapor stressed under acetonitrile at 25 'C for 2 days resulting in the formation of irregular fragments of crystals which were determined to be Pattern G material 10 by XRPD. Amorphous Compound 1 was also slurried in methanol\water (1:1) for 5 days at 60 'C resulting in irregular fragments of crystals determined to be Form B by XRPD. This indicates that the amorphous solid was physically unstable and readily crystallized. The physical stability of polymorph Form A was characterized. A samples of Form A exposed to 5 to 95% relative humidity at 25 'C (5 hours) showed only negligible weight 15 change indicating the material is non-hygroscopic. The physical stability of polymorph Form B was characterized. Samples of Form B were stressed under 75% relative humidity (40 'C) and 60% relative humidity (25 'C) for 1 month were also unchanged by XRPD, indicating that Farm B is stable under the conditions tested. 20 CHARACTERIZATION EXAMPLE 4 Relative Stability Experiments for Polymorph Form A and Form B Interconversion slurry experiments were performed in a variety of solvents at different temperatures. Sufficient amounts of Compound 1 were added to solvents in vials so that excess solid remained. The mixtures were agitated in sealed vials at the selected temperature 25 and the solids were isolated by filtration after the selected time and analyzed by XRPD. Compound 1 slurried in acetonitrile for 3 days at 83 'C or for 8 days at 0 'C yielded Pattern G solid. Compound 1 slurried in acetonitrile/water (9:1) for 3 days at 83 'C yielded polymorph Form B. Compound 1 slurried in acetonitrile/water (9:1) for 8 days at 0 'C yielded Pattern G solid. 30 CHARACTERIZATION EXAMPLE 5 Vacuum Drying Experiment Conversion of Pattern G solid to Form A was achieved by vacuum drying (36-68 mtorr) Pattern G solid at 50 'C for 4 hours. Vacuum drying (51 mtorr) at 70 'C for 5 hours caused Pattern G solid to become a solid glass. 35 Compound 1 can be prepared according to the procedures disclosed in PCT Patent Publications WO 09/025983) and WO 09/126668.
13 PREPARATION EXAMPLE 1 Initial Preparation of Polymorph Form B of Compound 1 Crude Compound 1 (10.2 g) was added to boiling methanol (60 mL). Water (12 mL) was slowly added, followed by a small amount of methanol. The heat was removed, the 5 reaction mixture was allowed to cool briefly, and then seed crystals of Compound 1 Form A were added. The reaction mixture was cooled to room temperature (seed crystals were again added until they no longer dissolved), and then further cooled to about 0 'C for 24 h. The reaction mixture was filtered to yield 6.0 g of a white solid melting at 100-105 'C (NMR indicates solvent contamination). 10 The filtrate from above was allowed to sit for approximately 30 days at room temperature, resulting in the formation of a second crop of crystals. The crystals were isolated by filtration, washed with water, briefly air dried, and finally dried under vacuum at 50 'C to yield 2.9 g of a white solid melting at 144-150 'C. PREPARATION EXAMPLE 2 15 Preparation of Polymorph Form B of Compound 1 from Polymorph Form A Compound 1 Form A (15.3 g) was added to methanol (120 g) and water (50.4 g). The reaction mixture was heated to 40 'C, and after 10 min seed crystals of Compound 1 (Form B) were added. The reaction mixture was stirred at 35 'C for 72 h, cooled to room temperature, and filtered. The isolated solid was dried in a vacuum oven at 50-60 'C to yield 20 13.4 g of a white solid melting at 147-149 'C. PREPARATION EXAMPLE 3 Preparation of Polymorph Form B of Compound 1 Using Seed Crystals Compound 1 (95 g) was added to methanol (408 g). The mixture was mechanically stirred and heated to 30 'C to dissolve the solid completely. Water (129 g) was added 25 dropwise until the solution was turbid and seed crystals of Form B were added. The mixture was allowed to cool to 25 'C and stirred for 3.5 hours. A thick white solid began to precipitate and the mixture was then heated to 45 'C for 1 hour and cooled to 25 'C over 45 minutes. The mixture was heated again to 45 'C for 50 minutes and then cooled to 25 'C over 40 minutes and filtered. The temperature cycling enables the crystals to grow to a 30 larger size to enable filtration. The crystals were washed with a cold mixture of methanol\water (95 mL of 3:1) and dried in a vacuum oven at 50 'C for 16 hours to give 82 g of a white solid melting at 145-148 'C. Agronomic Formulation/Utility 35 A compound of this invention will generally be used as an invertebrate pest control active ingredient in a composition, i.e. formulation, with at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, which 14 serves as a carrier. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Useful formulations include both liquid and solid compositions. Liquid compositions 5 include solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like, which optionally can be thickened into gels. The general types of aqueous liquid compositions are soluble concentrate, suspension concentrate, capsule suspension, concentrated emulsion, microemulsion and suspo-emulsion. The general types of nonaqueous liquid compositions are emulsifiable concentrate, 10 microemulsifiable concentrate, dispersible concentrate and oil dispersion. The general types of solid compositions are dusts, powders, granules, pellets, prills, pastilles, tablets, filled films (including seed coatings) and the like, which can be water-dispersible ("wettable") or water-soluble. Films and coatings formed from film forming solutions or flowable suspensions are particularly useful for seed treatment. Active 15 ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or "overcoated"). Encapsulation can control or delay release of the active ingredient. An emulsifiable granule combines the advantages of both an emulsifiable concentrate formulation and a dry granular formulation. High-strength compositions are primarily used 20 as intermediates for further formulation. Sprayable formulations are typically extended in a suitable medium before spraying. Such liquid and solid formulations are formulated to be readily diluted in the spray medium, usually water. Spray volumes can range from about one to several thousand liters per hectare, but more typically are in the range from about ten to several hundred liters per 25 hectare. Sprayable formulations can be tank mixed with water or another suitable medium for foliar treatment by aerial or ground application, or for application to the growing medium of the plant. Liquid and dry formulations can be metered directly into drip irrigation systems or metered into the furrow during planting. Liquid and solid formulations can be applied onto seeds of crops and other desirable vegetation as seed treatments before planting to 30 protect developing roots and other subterranean plant parts and/or foliage through systemic uptake. The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up to 100 percent by weight.
15 Weight Percent Active Ingredient Diluent Surfactant Water-Dispersible Granules, 0.001-90 0-99.999 0-15 Tablets and Powders Oil Dispersions, Aqueous 1-50 40-99 0-50 Suspensions Dusts 1-25 70-99 0-5 Granules and Pellets 0.001-95 5-99.999 0-15 High Strength Compositions 90-99 0-10 0-2 Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, gypsum, cellulose, titanium dioxide, zinc oxide, starch, dextrin, sugars (e.g., lactose, sucrose), silica, talc, mica, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Typical solid diluents are described 5 in Watkins et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Liquid diluents include, for example, water, N,N-dimethylalkanamides (e.g., N,N-dimethylformamide), limonene, dimethyl sulfoxide, N-alkylpyrrolidones (e.g., N-methylpyrrolidinone), ethylene glycol, triethylene glycol, propylene glycol, dipropylene 10 glycol, polypropylene glycol, propylene carbonate, butylene carbonate, paraffins (e.g., white mineral oils, normal paraffins, isoparaffins), alkylbenzenes, alkylnaphthalenes, glycerine, glycerol triacetate, sorbitol, aromatic hydrocarbons, dearomatized aliphatics, alkylbenzenes, alkylnaphthalenes, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy 4-methyl-2-pentanone, acetates such as isoamyl acetate, hexyl acetate, heptyl acetate, octyl 15 acetate, nonyl acetate, tridecyl acetate and isobornyl acetate, other esters such as alkylated lactate esters, dibasic esters and -butyrolactone, and alcohols, which can be linear, branched, saturated or unsaturated, such as methanol, ethanol, n-propanol, isopropyl alcohol, n-butanol, isobutyl alcohol, n-hexanol, 2-ethylhexanol, n-octanol, decanol, isodecyl alcohol, isooctadecanol, cetyl alcohol, lauryl alcohol, tridecyl alcohol, oleyl alcohol, cyclohexanol, 20 tetrahydrofurfuryl alcohol, diacetone alcohol and benzyl alcohol. Liquid diluents also include glycerol esters of saturated and unsaturated fatty acids (typically
C
6
-C
2 2), such as plant seed and fruit oils (e.g., oils of olive, castor, linseed, sesame, corn (maize), peanut, sunflower, grapeseed, safflower, cottonseed, soybean, rapeseed, coconut and palm kernel), animal-sourced fats (e.g., beef tallow, pork tallow, lard, cod liver oil, fish 25 oil), and mixtures thereof. Liquid diluents also include alkylated fatty acids (e.g., methylated, ethylated, butylated) wherein the fatty acids may be obtained by hydrolysis of glycerol esters from plant and animal sources, and can be purified by distillation. Typical 16 liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. The solid and liquid compositions of the present invention often include one or more surfactants. When added to a liquid, surfactants (also known as "surface-active agents") 5 generally modify, most often reduce, the surface tension of the liquid. Depending on the nature of the hydrophilic and lipophilic groups in a surfactant molecule, surfactants can be useful as wetting agents, dispersants, emulsifiers or defoaming agents. Surfactants can be classified as nonionic, anionic or cationic. Nonionic surfactants useful for the present compositions include, but are not limited to: alcohol alkoxylates such 10 as alcohol alkoxylates based on natural and synthetic alcohols (which may be branched or linear) and prepared from the alcohols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof; amine ethoxylates, alkanolamides and ethoxylated alkanolamides; alkoxylated triglycerides such as ethoxylated soybean, castor and rapeseed oils; alkylphenol alkoxylates such as octylphenol ethoxylates, nonylphenol ethoxylates, dinonyl phenol 15 ethoxylates and dodecyl phenol ethoxylates (prepared from the phenols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); block polymers prepared from ethylene oxide or propylene oxide and reverse block polymers where the terminal blocks are prepared from propylene oxide; ethoxylated fatty acids; ethoxylated fatty esters and oils; ethoxylated methyl esters; ethoxylated tristyrylphenol (including those prepared from 20 ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); fatty acid esters, glycerol esters, lanolin-based derivatives, polyethoxylate esters such as polyethoxylated sorbitan fatty acid esters, polyethoxylated sorbitol fatty acid esters and polyethoxylated glycerol fatty acid esters; other sorbitan derivatives such as sorbitan esters; polymeric surfactants such as random copolymers, block copolymers, alkyd peg (polyethylene glycol) 25 resins, graft or comb polymers and star polymers; polyethylene glycols (pegs); polyethylene glycol fatty acid esters; silicone-based surfactants; and sugar-derivatives such as sucrose esters, alkyl polyglycosides and alkyl polysaccharides. Useful anionic surfactants include, but are not limited to: alkylaryl sulfonic acids and their salts; carboxylated alcohol or alkylphenol ethoxylates; diphenyl sulfonate derivatives; 30 lignin and lignin derivatives such as lignosulfonates; maleic or succinic acids or their anhydrides; olefin sulfonates; phosphate esters such as phosphate esters of alcohol alkoxylates, phosphate esters of alkylphenol alkoxylates and phosphate esters of styryl phenol ethoxylates; protein-based surfactants; sarcosine derivatives; styryl phenol ether sulfate; sulfates and sulfonates of oils and fatty acids; sulfates and sulfonates of ethoxylated 35 alkylphenols; sulfates of alcohols; sulfates of ethoxylated alcohols; sulfonates of amines and amides such as N,N-alkyltaurates; sulfonates of benzene, cumene, toluene, xylene, and dodecyl and tridecylbenzenes; sulfonates of condensed naphthalenes; sulfonates of 17 naphthalene and alkyl naphthalene; sulfonates of fractionated petroleum; sulfosuccinamates; and sulfosuccinates and their derivatives such as dialkyl sulfosuccinate salts. Useful cationic surfactants include, but are not limited to: amides and ethoxylated amides; amines such as N-alkyl propanediamines, tripropylenetriamines and 5 dipropylenetetramines, and ethoxylated amines, ethoxylated diamines and propoxylated amines (prepared from the amines and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); amine salts such as amine acetates and diamine salts; quaternary ammonium salts such as quaternary salts, ethoxylated quaternary salts and diquaternary salts; and amine oxides such as alkyldimethylamine oxides and bis-(2-hydroxyethyl)-alkylamine 10 oxides. Also useful for the present compositions are mixtures of nonionic and anionic surfactants or mixtures of nonionic and cationic surfactants. Nonionic, anionic and cationic surfactants and their recommended uses are disclosed in a variety of published references including McCutcheon's Emulsifiers and Detergents, annual American and International 15 Editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964; and A. S. Davidson and B. Milwidsky, Synthetic Detergents, Seventh Edition, John Wiley and Sons, New York, 1987. Compositions of this invention may also contain formulation auxiliaries and additives, 20 known to those skilled in the art as formulation aids (some of which may be considered to also function as solid diluents, liquid diluents or surfactants). Such formulation auxiliaries and additives may control: pH (buffers), foaming during processing (antifoams such polyorganosiloxanes), sedimentation of active ingredients (suspending agents), viscosity (thixotropic thickeners), in-container microbial growth (antimicrobials), product freezing 25 (antifreezes), color (dyes/pigment dispersions), wash-off (film formers or stickers), evaporation (evaporation retardants), and other formulation attributes. Film formers include, for example, polyvinyl acetates, polyvinyl acetate copolymers, polyvinylpyrrolidone-vinyl acetate copolymer, polyvinyl alcohols, polyvinyl alcohol copolymers and waxes. Examples of formulation auxiliaries and additives include those listed in McCutcheon's Volume 2: 30 Functional Materials, annual International and North American editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; and PCT Publication WO 03/024222. The compound of Formula 1 and any other active ingredients are typically incorporated into the present compositions by dissolving the active ingredient in a solvent or 35 by grinding in a liquid or dry diluent. Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. If the solvent of a liquid composition intended for use as an emulsifiable concentrate is water-immiscible, an emulsifier is typically added to emulsify the active-containing solvent upon dilution with water. Active ingredient slurries, 18 with particle diameters of up to 2,000 m can be wet milled using media mills to obtain particles with average diameters below 3 m. Aqueous slurries can be made into finished suspension concentrates (see, for example, U.S. 3,060,084) or further processed by spray drying to form water-dispersible granules. Dry formulations usually require dry milling 5 processes, which produce average particle diameters in the 2 to 10 m range. Dusts and powders can be prepared by blending and usually grinding (such as with a hammer mill or fluid-energy mill). Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4, 1967, pp 147-48, Perry's Chemical 10 Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following, and WO 91/13546. Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in U.S. 4,144,050, U.S. 3,920,442 and DE 3,246,493. Tablets can be prepared as taught in U.S. 5,180,587, U.S. 5,232,701 and U.S. 5,208,030. Films can be prepared as taught in GB 2,095,558 and U.S. 15 3,299,566. For further information regarding the art of formulation, see T. S. Woods, "The Formulator's Toolbox - Product Forms for Modem Agriculture" in Pesticide Chemistry and Bioscience, The Food-Environment Challenge, T. Brooks and T. R. Roberts, Eds., Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of 20 Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10-41; U.S. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; Hance et al., 25 Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989; and Developments informulation technology, PJB Publications, Richmond, UK, 2000. In the following Examples, all formulations are prepared in conventional ways. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples 30 are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except where otherwise indicated. Example A High Strength Concentrate Compound 1 98.5% silica aerogel 0.5% synthetic amorphous fine silica 1.0% 19 Example B Wettable Powder Compound 1 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0% Example C Granule Compound 1 10.0% attapulgite granules (low volatile matter, 0.71/0.30 mm; 90.0% U.S.S. No. 25-50 sieves) Example D Extruded Pellet Compound 1 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0% Example E Emulsifiable Concentrate Compound 1 10.0% polyoxyethylene sorbitol hexoleate 20.0%
C
6
-C
10 fatty acid methyl ester 70.0% 5 Example F Microemulsion Compound 1 5.0% polyvinylpyrrolidone-vinyl acetate copolymer 30.0% alkylpolyglycoside 30.0% glyceryl monooleate 15.0% water 20.0% Example G Seed Treatment Compound 1 20.00% polyvinylpyrrolidone-vinyl acetate copolymer 5.00% montan acid wax 5.00% calcium ligninsulfonate 1.00% polyoxyethylene/polyoxypropylene block copolymers 1.00% 20 stearyl alcohol (POE 20) 2.00% polyorganosilane 0.20% colorant red dye 0.05% water 65.75% Example H Fertilizer Stick Compound 1 2.50% pyrrolidone-styrene copolymer 4.80% tristyrylphenyl 16-ethoxylate 2.30% talc 0.80% corn starch 5.00% slow-release fertilizer 36.00% kaolin 38.00% water 10.60% Example I Suspension Concentrate Compound 1 35% butyl polyoxyethylene/polypropylene block copolymer 4.0% stearic acid/polyethylene glycol copolymer 1.0% styrene acrylic polymer 1.0% xanthan gum 0.1% propylene glycol 5.0% silicone based defoamer 0.1% 1,2-benzisothiazolin-3-one 0.1% water 53.7% Example J Emulsion in Water Compound 1 10.0% butyl polyoxyethylene/polypropylene block copolymer 4.0% stearic acid/polyethylene glycol copolymer 1.0% styrene acrylic polymer 1.0% xanthan gum 0.1% propylene glycol 5.0% silicone based defoamer 0.1% 1,2-benzisothiazolin-3-one 0.1% aromatic petroleum based hydrocarbon 20.0 water 58.7% 21 Example K Oil Dispersion Compound 1 25% polyoxyethylene sorbitol hexaoleate 15% organically modified bentonite clay 2.5% fatty acid methyl ester 57.5% Example L Suspoemulsion Compound 1 10.0% fipronil (second active ingredient) 5.0% butyl polyoxyethylene/polypropylene block copolymer 4.0% stearic acid/polyethylene glycol copolymer 1.0% styrene acrylic polymer 1.0% xanthan gum 0.1% propylene glycol 5.0% silicone based defoamer 0.1% 1,2-benzisothiazolin-3-one 0.1% aromatic petroleum based hydrocarbon 20.0% water 53.7% Compounds of this invention exhibit activity against a wide spectrum of invertebrate 5 pests. These pests include invertebrates inhabiting a variety of environments such as, for example, plant foliage, roots, soil, harvested crops or other foodstuffs, building structures or animal integuments. These pests include, for example, invertebrates feeding on foliage (including leaves, stems, flowers and fruits), seeds, wood, textile fibers or animal blood or tissues, and thereby causing injury or damage to, for example, growing or stored agronomic 10 crops, forests, greenhouse crops, ornamentals, nursery crops, stored foodstuffs or fiber products, or houses or other structures or their contents, or being harmful to animal health or public health. Those skilled in the art will appreciate that not all compounds are equally effective against all growth stages of all pests. These present compounds and compositions are thus useful agronomically for 15 protecting field crops from phytophagous invertebrate pests, and also nonagronomically for protecting other horticultural crops and plants from phytophagous invertebrate pests. This utility includes protecting crops and other plants (i.e. both agronomic and nonagronomic) that contain genetic material introduced by genetic engineering (i.e. transgenic) or modified by mutagenesis to provide advantageous traits. Examples of such traits include tolerance to 20 herbicides, resistance to phytophagous pests (e.g., insects, mites, aphids, spiders, nematodes, snails, plant-pathogenic fungi, bacteria and viruses), improved plant growth, increased 22 tolerance of adverse growing conditions such as high or low temperatures, low or high soil moisture, and high salinity, increased flowering or fruiting, greater harvest yields, more rapid maturation, higher quality and/or nutritional value of the harvested product, or improved storage or process properties of the harvested products. Transgenic plants can be modified 5 to express multiple traits. Examples of plants containing traits provided by genetic engineering or mutagenesis include varieties of corn, cotton, soybean and potato expressing an insecticidal Bacillus thuringiensis toxin such as YIELD GARD , KNOCKOUT®, STARLINK®, BOLLGARD®, NuCOTN@ and NEWLEAF®, and herbicide-tolerant varieties of corn, cotton, soybean and rapeseed such as ROUNDUP READY , LIBERTY LINK 10 IMI®, STS @ and CLEARFIELD @, as well as crops expressing N-acetyltransferase (GAT) to provide resistance to glyphosate herbicide, or crops containing the HRA gene providing resistance to herbicides inhibiting acetolactate synthase (ALS). The present compounds and compositions may interact synergistically with traits introduced by genetic engineering or modified by mutagenesis, thus enhancing phenotypic expression or effectiveness of the traits 15 or increasing the invertebrate pest control effectiveness of the present compounds and compositions. In particular, the present compounds and compositions may interact synergistically with the phenotypic expression of proteins or other natural products toxic to invertebrate pests to provide greater-than-additive control of these pests. Compositions of this invention can also optionally comprise plant nutrients, e.g., a 20 fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium, magnesium, iron, copper, boron, manganese, zinc, and molybdenum. Of note are compositions comprising at least one fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium and magnesium. Compositions of the present invention which further comprise at 25 least one plant nutrient can be in the form of liquids or solids. Of note are solid formulations in the form of granules, small sticks or tablets. Solid formulations comprising a fertilizer composition can be prepared by mixing the compound or composition of the present invention with the fertilizer composition together with formulating ingredients and then preparing the formulation by methods such as granulation or extrusion. Alternatively solid 30 formulations can be prepared by spraying a solution or suspension of a compound or composition of the present invention in a volatile solvent onto a previous prepared fertilizer composition in the form of dimensionally stable mixtures, e.g., granules, small sticks or tablets, and then evaporating the solvent. Agronomic and nonagronomic pests 35 Examples of agronomic or nonagronomic invertebrate pests include eggs, larvae and adults of the order Lepidoptera, such as armyworms, cutworms, loopers, and heliothines in the family Noctuidae (e.g., pink stem borer (Sesamia inferens Walker), corn stalk borer (Sesamia nonagrioides Lefebvre), southern arnyworm (Spodoptera eridania Cramer), fall 23 arnyworm (Spodoptera fugiperda J. E. Smith), beet arnyworm (Spodoptera exigua HUbner), cotton leafworm (Spodoptera littoralis Boisduval), yellowstriped armyworm (Spodoptera ornithogalli Guen6e), black cutworm (Agrotis ipsilon Hufnagel), velvetbean caterpillar (Anticarsia gemmatalis HUbner), green fruitworm (Lithophane antennata 5 Walker), cabbage armyworm (Barathra brassicae Linnaeus), soybean looper (Pseudoplusia includens Walker), cabbage looper (Trichoplusia ni HUbner), tobacco budworm (Heliothis virescens Fabricius)); borers, casebearers, webworms, coneworms, cabbageworms and skeletonizers from the family Pyralidae (e.g., European corn borer (Ostrinia nubilalis HUbner), navel orangeworm (Amyelois transitella Walker), corn root webworm (Crambus 10 caliginosellus Clemens), sod webworms (Pyralidae: Crambinae) such as sod worm (Herpetogramma licarsisalis Walker), sugarcane stem borer (Chilo infuscatellus Snellen), tomato small borer (Neoleucinodes elegantalis Guen6e), green leafroller (Cnaphalocerus medinalis), grape leaffolder (Desmia funeralis HUbner), melon worm (Diaphania nitidalis Stoll), cabbage center grub (Helluala hydralis Guen6e), yellow stem borer (Scirpophaga 15 incertulas Walker), early shoot borer (Scirpophaga infuscatellus Snellen), white stem borer (Scirpophaga innotata Walker), top shoot borer (Scirpophaga nivella Fabricius), dark headed rice borer (Chilo polychrysus Meyrick), cabbage cluster caterpillar (Crocidolomia binotalis English)); leafrollers, budworms, seed worms, and fruit worms in the family Tortricidae (e.g., codling moth (Cydia pomonella Linnaeus), grape berry moth (Endopiza 20 viteana Clemens), oriental fruit moth (Grapholita molesta Busck), citrus false codling moth (Cryptophlebia leucotreta Meyrick), citrus borer (Ecdytolopha aurantiana Lima), redbanded leafroller (Argyrotaenia velutinana Walker), obliquebanded leafroller (Choristoneura rosaceana Harris), light brown apple moth (Epiphyas postvittana Walker), European grape berry moth (Eupoecilia ambiguella HUbner), apple bud moth (Pandemis pyrusana Kearfott), 25 omnivorous leafroller (Platynota stultana Walsingham), barred fruit-tree tortrix (Pandemis cerasana HUbner), apple brown tortrix (Pandemis heparana Denis & SchiffermUller)); and many other economically important lepidoptera (e.g., diamondback moth (Plutella xylostella Linnaeus), pink bollworm (Pectinophora gossypiella Saunders), gypsy moth (Lymantria dispar Linnaeus), peach fruit borer (Carposina niponensis Walsingham), peach twig borer 30 (Anarsia lineatella Zeller), potato tuberworm (Phthorimaea operculella Zeller), spotted teniform leafminer (Lithocolletis blancardella Fabricius), Asiatic apple leafminer (Lithocolletis ringoniella Matsumura), rice leaffolder (Lerodea eufala Edwards), apple leafminer (Leucoptera scitella Zeller)); eggs, nymphs and adults of the order Blattodea including cockroaches from the families Blattellidae and Blattidae (e.g., oriental cockroach 35 (Blatta orientalis Linnaeus), Asian cockroach (Blatella asahinai Mizukubo), German cockroach (Blattella germanica Linnaeus), brownbanded cockroach (Supella longipalpa Fabricius), American cockroach (Periplaneta americana Linnaeus), brown cockroach (Periplaneta brunnea Burmeister), Madeira cockroach (Leucophaea maderae Fabricius)), 24 smoky brown cockroach (Periplaneta fuliginosa Service), Australian Cockroach (Periplaneta australasiae Fabr.), lobster cockroach (Nauphoeta cinerea Olivier) and smooth cockroach (Symploce pallens Stephens)); eggs, foliar feeding, fruit feeding, root feeding, seed feeding and vesicular tissue feeding larvae and adults of the order Coleoptera including 5 weevils from the families Anthribidae, Bruchidae, and Curculionidae (e.g., boll weevil (Anthonomus grandis Boheman), rice water weevil (Lissorhoptrus oryzophilus Kuschel), granary weevil (Sitophilus granarius Linnaeus), rice weevil (Sitophilus oryzae Linnaeus)), annual bluegrass weevil (Listronotus maculicollis Dietz), bluegrass billbug (Sphenophorus parvulus Gyllenhal), hunting billbug (Sphenophorus venatus vestitus), Denver billbug 10 (Sphenophorus cicatristriatus Fahraeus)); flea beetles, cucumber beetles, rootworms, leaf beetles, potato beetles, and leafminers in the family Chrysomelidae (e.g., Colorado potato beetle (Leptinotarsa decemlineata Say), western corn rootworm (Diabrotica virgifera virgifera LeConte)); chafers and other beetles from the family Scarabaeidae (e.g., Japanese beetle (Popillia japonica Newman), oriental beetle (Anomala orientalis Waterhouse, 15 Exomala orientalis (Waterhouse) Baraud), northern masked chafer (Cyclocephala borealis Arrow), southern masked chafer (Cyclocephala immaculata Olivier or C. lurida Bland), dung beetle and white grub (Aphodius spp.), black turfgrass ataenius (Ataenius spretulus Haldeman), green June beetle (Cotinis nitida Linnaeus), Asiatic garden beetle (Maladera castanea Arrow), May/June beetles (Phyllophaga spp.) and European chafer (Rhizotrogus 20 majalis Razoumowsky)); carpet beetles from the family Dermestidae; wireworms from the family Elateridae; bark beetles from the family Scolytidae and flour beetles from the family Tenebrionidae. In addition, agronomic and nonagronomic pests include: eggs, adults and larvae of the order Dermaptera including earwigs from the family Forficulidae (e.g., European earwig (Forficula auricularia Linnaeus), black earwig (Chelisoches morio 25 Fabricius)); eggs, immatures, adults and nymphs of the orders Hemiptera and Homoptera such as, plant bugs from the family Miridae, cicadas from the family Cicadidae, leafhoppers (e.g. Empoasca spp.) from the family Cicadellidae, bed bugs (e.g., Cimex lectularius Linnaeus) from the family Cimicidae, planthoppers from the families Fulgoroidae and Delphacidae, treehoppers from the family Membracidae, psyllids from the family Psyllidae, 30 whiteflies from the family Aleyrodidae, aphids from the family Aphididae, phylloxera from the family Phylloxeridae, mealybugs from the family Pseudococcidae, scales from the families Coccidae, Diaspididae and Margarodidae, lace bugs from the family Tingidae, stink bugs from the family Pentatomidae, chinch bugs (e.g., hairy chinch bug (Blissus leucopterus hirtus Montandon) and southern chinch bug (Blissus insularis Barber)) and other seed bugs 35 from the family Lygaeidae, spittlebugs from the family Cercopidae squash bugs from the family Coreidae, and red bugs and cotton stainers from the family Pyrrhocoridae. Also included are eggs, larvae, nymphs and adults of the order Acari (mites) such as spider mites and red mites in the family Tetranychidae (e.g., European red mite (Panonychus ulmi Koch), 25 two spotted spider mite (Tetranychus urticae Koch), McDaniel mite (Tetranychus mcdanieli McGregor)); flat mites in the family Tenuipalpidae (e.g., citrus flat mite (Brevipalpus lewisi McGregor)); rust and bud mites in the family Eriophyidae and other foliar feeding mites and mites important in human and animal health, i.e. dust mites in the family Epidermoptidae, 5 follicle mites in the family Demodicidae, grain mites in the family Glycyphagidae; ticks in the family Ixodidae, commonly known as hard ticks (e.g., deer tick (Ixodes scapularis Say), Australian paralysis tick (Ixodes holocyclus Neumann), American dog tick (Dermacentor variabilis Say), lone star tick (Amblyomma americanum Linnaeus)) and ticks in the family Argasidae, commonly known as soft ticks (e.g., relapsing fever tick (Ornithodoros turicata), 10 common fowl tick (Argas radiatus)); scab and itch mites in the families Psoroptidae, Pyemotidae, and Sarcoptidae; eggs, adults and immatures of the order Orthoptera including grasshoppers, locusts and crickets (e.g., migratory grasshoppers (e.g., Melanoplus sanguinipes Fabricius, M. differentialis Thomas), American grasshoppers (e.g., Schistocerca americana Drury), desert locust (Schistocerca gregaria Forskal), migratory locust (Locusta 15 migratoria Linnaeus), bush locust (Zonocerus spp.), house cricket (Acheta domesticus Linnaeus), mole crickets (e.g., tawny mole cricket (Scapteriscus vicinus Scudder) and southern mole cricket (Scapteriscus borellii Giglio-Tos)); eggs, adults and immatures of the order Diptera including leafminers (e.g., Liriomyza spp. such as serpentine vegetable leafminer (Liriomyza sativae Blanchard)), midges, fruit flies (Tephritidae), frit flies (e.g., 20 Oscinella frit Linnaeus), soil maggots, house flies (e.g., Musca domestica Linnaeus), lesser house flies (e.g., Fannia canicularis Linnaeus, F. femoralis Stein), stable flies (e.g., Stomoxys calcitrans Linnaeus), face flies, horn flies, blow flies (e.g., Chrysomya spp., Phormia spp.), and other muscoid fly pests, horse flies (e.g., Tabanus spp.), bot flies (e.g., Gastrophilus spp., Oestrus spp.), cattle grubs (e.g., Hypoderma spp.), deer flies (e.g., 25 Chrysops spp.), keds (e.g., Melophagus ovinus Linnaeus) and other Brachycera, mosquitoes (e.g., Aedes spp., Anopheles spp., Culex spp.), black flies (e.g., Prosimulium spp., Simulium spp.), biting midges, sand flies, sciarids, and other Nematocera; eggs, adults and immatures of the order Thysanoptera including onion thrips (Thrips tabaci Lindeman), flower thrips (Frankliniella spp.), and other foliar feeding thrips; insect pests of the order Hymenoptera 30 including ants of the Family Formicidae including the Florida carpenter ant (Camponotus floridanus Buckley), red carpenter ant (Camponotus ferrugineus Fabricius), black carpenter ant (Camponotus pennsylvanicus De Geer), white-footed ant (Technomyrmex albipes fr. Smith), big headed ants (Pheidole sp.), ghost ant (Tapinoma melanocephalum Fabricius); Pharaoh ant (Monomorium pharaonis Linnaeus), little fire ant (Wasmannia auropunctata 35 Roger), fire ant (Solenopsis geminata Fabricius), red imported fire ant (Solenopsis invicta Buren), Argentine ant (Iridomyrmex humilis Mayr), crazy ant (Paratrechina longicornis Latreille), pavement ant (Tetramorium caespitum Linnaeus), cornfield ant (Lasius alienus F6rster) and odorous house ant (Tapinoma sessile Say). Other Hymenoptera including bees 26 (including carpenter bees), hornets, yellow jackets, wasps, and sawflies (Neodiprion spp.; Cephus spp.); insect pests of the order Isoptera including termites in the Termitidae (e.g., Macrotermes sp., Odontotermes obesus Rambur), Kalotermitidae (e.g., Cryptotermes sp.), and Rhinotermitidae (e.g., Reticulitermes sp., Coptotermes sp., Heterotermes tenuis Hagen) 5 families, the eastern subterranean termite (Reticulitermes flavipes Kollar), western subterranean termite (Reticulitermes hesperus Banks), Formosan subterranean termite (Coptotermes formosanus Shiraki), West Indian drywood termite (Incisitermes immigrans Snyder), powder post termite (Cryptotermes brevis Walker), drywood termite (Incisitermes snyderi Light), southeastern subterranean termite (Reticulitermes virginicus Banks), western 10 drywood termite (Incisitermes minor Hagen), arboreal termites such as Nasutitermes sp. and other termites of economic importance; insect pests of the order Thysanura such as silverfish (Lepisma saccharina Linnaeus) and firebrat (Thermobia domestica Packard); insect pests of the order Mallophaga and including the head louse (Pediculus humanus capitis De Geer), body louse (Pediculus humanus Linnaeus), chicken body louse (Menacanthus stramineus 15 Nitszch), dog biting louse (Trichodectes canis De Geer), fluff louse (Goniocotes gallinae De Geer), sheep body louse (Bovicola ovis Schrank), short-nosed cattle louse (Haematopinus eurysternus Nitzsch), long-nosed cattle louse (Linognathus vituli Linnaeus) and other sucking and chewing parasitic lice that attack man and animals; insect pests of the order Siphonoptera including the oriental rat flea (Xenopsylla cheopis Rothschild), cat flea 20 (Ctenocephalides felis Bouche), dog flea (Ctenocephalides canis Curtis), hen flea (Ceratophyllus gallinae Schrank), sticktight flea (Echidnophaga gallinacea Westwood), human flea (Pulex irritans Linnaeus) and other fleas afflicting mammals and birds. Additional arthropod pests covered include: spiders in the order Araneae such as the brown recluse spider (Loxosceles reclusa Gertsch & Mulaik) and the black widow spider 25 (Latrodectus mactans Fabricius), and centipedes in the order Scutigeromorpha such as the house centipede (Scutigera coleoptrata Linnaeus). Compounds of the present invention also have activity on members of the Classes Nematoda, Cestoda, Trematoda, and Acanthocephala including economically important members of the orders Strongylida, Ascaridida, Oxyurida, Rhabditida, Spirurida, and Enoplida such as but not limited to 30 economically important agricultural pests (i.e. root knot nematodes in the genus Meloidogyne, lesion nematodes in the genus Pratylenchus, stubby root nematodes in the genus Trichodorus, etc.) and animal and human health pests (i.e. all economically important flukes, tapeworms, and roundworms, such as Strongylus vulgaris in horses, Toxocara canis in dogs, Haemonchus contortus in sheep, Dirofilaria immitis Leidy in dogs, Anoplocephala 35 perfoliata in horses, Fasciola hepatica Linnaeus in ruminants, etc.). Compound 1 of the invention show particularly high activity against pests in the order Lepidoptera (e.g., Alabama argillacea HUbner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Archips 27 species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guen6e (rice leaf roller), Crambus caliginosellus Clemens (corn root webworm), Crambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa 5 armigera HUbner (American bollworm), Helicoverpa zea Boddie (corn earworm), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (sod webworm), Lobesia botrana Denis & SchiffermUller (grape berry moth), Pectinophora gossypiella Saunders (pink bollworm), Phyllocnistis citrella Stainton (citrus leafminer), Pieris brassicae Linnaeus (large white butterfly), Pieris rapae Linnaeus (small white 10 butterfly), Plutella xylostella Linnaeus (diamondback moth), Spodoptera exigua HUbner (beet armyworm), Spodoptera litura Fabricius (tobacco cutworm, cluster caterpillar), Spodoptera frugiperda J. E. Smith (fall armyworm), Trichoplusia ni HUbner (cabbage looper) and Tuta absoluta Meyrick (tomato leafminer)). Compound 1 of the invention also have activity on members from the order Homoptera 15 including: Acyrthosiphon pisum Harris (pea aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aulacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea 20 Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopterus pruni Geoffroy (mealy plum aphid), Lipaphis erysimi Kaltenbach (turnip aphid), Metopolophium dirrhodum Walker (cereal aphid), Macrosiphum euphorbiae Thomas (potato aphid), Myzus persicae Sulzer (peach-potato aphid, green peach aphid), Nasonovia ribisnigri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), 25 Rhopalosiphum maidis Fitch (corn leaf aphid), Rhopalosiphum padi Linnaeus (bird cherry oat aphid), Schizaphis graminum Rondani (greenbug), Sitobion avenae Fabricius (English grain aphid), Therioaphis maculata Buckton (spotted alfalfa aphid), Toxoptera aurantii Boyer de Fonscolombe (black citrus aphid), and Toxoptera citricida Kirkaldy (brown citrus aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); 30 Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly), Bemisia argentifoii Bellows & Perring (silverleaf whitefly), Dialeurodes citri Ashmead (citrus whitefly) and Trialeurodes vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris (potato leafhopper), Laodelphax striatellus Fallen (smaller brown planthopper), Macrolestes quadrilineatus Forbes (aster leafhopper), Nephotettix cinticeps Uhler (green leafhopper), 35 Nephotettix nigropictus Stil (rice leafhopper), Nilaparvata lugens Stil (brown planthopper), Peregrinus maidis Ashmead (corn planthopper), Sogatella furcifera Horvath (white-backed planthopper), Sogatodes orizicola Muir (rice delphacid), Typhlocyba pomaria McAtee white apple leafhopper, Erythroneoura spp. (grape leafhoppers); Magicidada septendecim 28 Linnaeus (periodical cicada); Icerya purchasi Maskell (cottony cushion scale), Quadraspidiotus perniciosus Comstock (San Jose scale); Planococcus citri Risso (citrus mealybug); Pseudococcus spp. (other mealybug complex); Cacopsylla pyricola Foerster (pear psylla), Trioza diospyri Ashmead (persimmon psylla). 5 Compound 1 of this invention also have activity on members from the order Hemiptera including: Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Cimex lectularius Linnaeus (bed bug) Corythuca gossypii Fabricius (cotton lace bug), Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herrich-Schaffer (cotton stainer), Euchistus servus Say (brown stink 10 bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp. (complex of seed bugs), Leptoglossus corculus Say (leaf-footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper). Other insect 15 orders controlled by compounds of the invention include Thysanoptera (e.g., Frankliniella occidentalis Pergande (western flower thrips), Scirthothrips citri Moulton (citrus thrips), Sericothrips variabilis Beach (soybean thrips), and Thrips tabaci Lindeman (onion thrips); and the order Coleoptera (e.g., Leptinotarsa decemlineata Say (Colorado potato beetle), Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, 20 Athous or Limonius). Note that some contemporary classification systems place Homoptera as a suborder within the order Hemiptera. Of note is use of Compound 1 of this invention for controlling silverleaf whitefly (Bemisia argentifolii). Of note is use of Compound 1 of this invention for controlling 25 western flower thrip (Frankliniella occidentalis). Of note is use of Compound 1 of this invention for controlling potato leafhopper (Empoasca fabae). Of note is use of Compound 1 of this invention for controlling diamondback moth (Plutella xylostella). Of note is use of Compound 1 of this invention for controlling fall arnyworm (Spodoptera frugiperda). 30 Agronomic Mixtures/Compositions Compounds of this invention can also be mixed with one or more other biologically active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, herbicides, herbicide safeners, growth regulators such as insect molting inhibitors and rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, 35 feeding stimulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agronomic and nonagronomic utility. Thus the present invention also pertains to a composition comprising a biologically effective amount of a compound of Formula 1 and an effective 29 amount of at least one additional biologically active compound or agent and can further comprise at least one of surfactants, solid diluents or liquid diluents. For mixtures of the present invention, the other biologically active compounds or agents can be formulated together with the present compounds, including the compound of Formula 1, to form a 5 premix, or the other biologically active compounds or agents can be formulated separately from the present compounds, including the compound of Formula 1, and the two formulations combined together before application (e.g., in a spray tank) or, alternatively, applied in succession. Compound 1 of this invention can also be mixed with one or more other biologically 10 active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, herbicides, herbicide safeners, growth regulators such as insect molting inhibitors and rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agronomic 15 and nonagronomic utility. Thus the present invention also pertains to a composition comprising a biologically effective amount of a compound of Formula 1, at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, and at least one additional biologically active compound or agent. For mixtures of the present invention, the other biologically active compounds or agents can be 20 formulated together with the present compounds, including the compound of Formula 1, to form a premix, or the other biologically active compounds or agents can be formulated separately from the present compounds, including the compound of Formula 1, and the two formulations combined together before application (e.g., in a spray tank) or, alternatively, applied in succession. 25 Examples of such biologically active compounds or agents with which compounds of this invention can be formulated are insecticides such as abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, amidoflumet, amitraz, avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, bistrifluron, borate, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2 methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, buprofezin, 30 cadusafos, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clofentezin, clothianidin, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimehypo, 35 dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, flufenerim, flufenoxuron, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide, hexaflumuron, 30 hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methiodicarb, methomyl, methoprene, methoxychlor, methoxyfenozide, metofluthrin, milbemycin oxime, monocrotophos, nicotine, nitenpyram, nithiazine, novaluron, 5 noviflumuron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pymetrozine, pyrafluprole, pyrethrin, pyridaben, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, sulprofos, tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, terbufos, 10 tetrachlorvinphos, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap -sodium, tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumuron, Bacillus thuringiensis delta endotoxins, entomopathogenic bacteria, entomopathogenic viruses and entomopathogenic fungi. Of note are insecticides such as abamectin, acetamiprid, acrinathrin, amitraz, 15 avermectin, azadirachtin, bifenthrin, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2 methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, buprofezin, cadusafos, carbaryl, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, 20 dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenothiocarb, fenoxycarb, fenvalerate, fipronil, flonicamid, flubendiamide, flufenoxuron, fluvalinate, formetanate, fosthiazate, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, lufenuron, metaflumizone, methiodicarb, methomyl, methoprene, methoxyfenozide, nitenpyram, nithiazine, novaluron, oxamyl, pymetrozine, pyrethrin, 25 pyridaben, pyridalyl, pyriproxyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, tebufenozide, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, triflumuron, Bacillus thuringiensis delta-endotoxins, all strains of Bacillus thuringiensis and all strains of Nucleo polyhydrosis viruses. 30 One embodiment of biological agents for mixing with compounds of this invention include entomopathogenic bacteria such as Bacillus thuringiensis, and the encapsulated delta-endotoxins of Bacillus thuringiensis (e.g., Cellcap, MPV, MPVII); entomopathogenic fungi such as green muscardine fungus; and entomopathogenic (both naturally occurring and genetically modified) viruses including baculovirus, nucleopolyhedro virus (NPV) such as 35 Helicoverpa zea nucleopolyhedrovirus (HzNPV), Anagrapha falcifera nucleopolyhedrovirus (AfNPV); and granulosis virus (GV) such as Cydia pomonella granulosis virus (CpGV). Of particular note is such a combination where the other invertebrate pest control active ingredient belongs to a different chemical class or has a different site of action than 31 the compound of Formula 1. In certain instances, a combination with at least one other invertebrate pest control active ingredient having a similar spectrum of control but a different site of action will be particularly advantageous for resistance management. Thus, a composition of the present invention can further comprise a biologically effective amount of 5 at least one additional invertebrate pest control active ingredient having a similar spectrum of control but belonging to a different chemical class or having a different site of action. These additional biologically active compounds or agents include, but are not limited to, sodium channel modulators such as bifenthrin, cypermethrin, cyhalothrin, lambda cyhalothrin, cyfluthrin, beta-cyfluthrin, deltamethrin, dimefluthrin, esfenvalerate, 10 fenvalerate, indoxacarb, metofluthrin, profluthrin, pyrethrin and tralomethrin; cholinesterase inhibitors such as chlorpyrifos, methomyl, oxamyl, thiodicarb and triazamate; neonicotinoids such as acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid and thiamethoxam; insecticidal macrocyclic lactones such as spinetoram, spinosad, abamectin, avennectin and emamectin; GABA (y-aminobutyric acid)-gated 15 chloride channel antagonists such as avennectin or blockers such as ethiprole and fipronil; chitin synthesis inhibitors such as buprofezin, cyromazine, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron and triflumuron; juvenile hormone mimics such as diofenolan, fenoxycarb, methoprene and pyriproxyfen; octopamine receptor ligands such as amitraz; molting inhibitors and ecdysone agonists such as azadirachtin, methoxyfenozide 20 and tebufenozide; ryanodine receptor ligands such as ryanodine, anthranilic diamides such as chlorantraniliprole (see U.S. Patent 6,747,047, PCT Publications WO 2003/015518 and WO 2004/067528) and flubendiamide (see U.S. Patent 6,603,044); nereistoxin analogs such as cartap; mitochondrial electron transport inhibitors such as chlorfenapyr, hydramethylnon and pyridaben; lipid biosynthesis inhibitors such as spirodiclofen and spiromesifen; cyclodiene 25 insecticides such as dieldrin or endosulfan; pyrethroids; carbamates; insecticidal ureas; and biological agents including nucleopolyhedro viruses (NPV), members of Bacillus thuringiensis, encapsulated delta-endotoxins of Bacillus thuringiensis, and other naturally occurring or genetically modified insecticidal viruses. Further examples of biologically active compounds or agents with which compounds 30 of this invention can be formulated are: fungicides such as acibenzolar, aldimorph, ametoctradin, amisulbrom, azaconazole, azoxystrobin, benalaxyl, benomyl, benthiavalicarb, benthiavalicarb-isopropyl, binomial, biphenyl, bitertanol, blasticidin-S, Bordeaux mixture (Tribasic copper sulfate), boscalid/nicobifen, bromuconazole, bupirimate, buthiobate, carboxin, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, 35 chlozolinate, clotrimazole, copper oxychloride, copper salts such as copper sulfate and copper hydroxide, cyazofamid, cyflunamid, cymoxanil, cyproconazole, cyprodinil, dichlofluanid, diclocymet, diclomezine, dicloran, diethofencarb, difenoconazole, dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dinocap, discostrobin, 32 dithianon, dodemorph, dodine, econazole, etaconazole, edifenphos, epoxiconazole, ethaboxam, ethirimol, ethridiazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fencaramid, fenfuram, fenhexamide, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, ferbam, ferfurazoate, ferimzone, fluazinam, fludioxonil, 5 flumetover, fluopicolide, fluoxastrobin, fluquinconazole, fluquinconazole, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetyl-aluminum, fuberidazole, furalaxyl, furametapyr, hexaconazole, hymexazole, guazatine, imazalil, imibenconazole, iminoctadine, iodicarb, ipconazole, iprobenfos, iprodione, iprovalicarb, isoconazole, isoprothiolane, kasugamycin, kresoxim-methyl, mancozeb, mandipropamid, maneb, mapanipyrin, 10 mefenoxam, mepronil, metalaxyl, metconazole, methasulfocarb, metiram, metominostrobin/fenominostrobin, mepanipyrim, metrafenone, miconazole, myclobutanil, neo-asozin (ferric methanearsonate), nuarimol, octhilinone, ofurace, orysastrobin, oxadixyl, oxolinic acid, oxpoconazole, oxycarboxin, paclobutrazol, penconazole, pencycuron, penflufen, penthiopyrad, perfurazoate, phosphonic acid, phthalide, picobenzamid, 15 picoxystrobin, polyoxin, probenazole, prochloraz, procymidone, propamocarb, propamocarb-hydrochloride, propiconazole, propineb, proquinazid, prothioconazole, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyrazophos, pyrifenox, pyrimethanil, pyrifenox, pyrolnitrine, pyroquilon, quinconazole, quinoxyfen, quintozene, silthiofam, simeconazole, spiroxamine, streptomycin, sulfur, tebuconazole, tebufloquin, techrazene, 20 tecloftalam, tecnazene, tetraconazole, thiabendazole, thifluzamide, thiophanate, thiophanate methyl, thiram, tiadinil, tolclofos-methyl, tolyfluanid, triadimefon, triadimenol, triarimol, triazoxide, tridemorph, trimoprhamide tricyclazole, trifloxystrobin, triforine, triticonazole, uniconazole, validamycin, valifenalate, vinclozolin, zineb, ziram, and zoxamide; nematocides such as aldicarb, imicyafos, oxamyl and fenamiphos; bactericides such as 25 streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad. In certain instances, combinations of a compound of this invention with other biologically active (particularly invertebrate pest control) compounds or agents (i.e. active 30 ingredients) can result in a greater-than-additive (i.e. synergistic) effect. Reducing the quantity of active ingredients released in the environment while ensuring effective pest control is always desirable. When synergism of invertebrate pest control active ingredients occurs at application rates giving agronomically satisfactory levels of invertebrate pest control, such combinations can be advantageous for reducing crop production cost and 35 decreasing environmental load. Compounds of this invention and compositions thereof can be applied to plants genetically transformed to express proteins toxic to invertebrate pests (such as Bacillus thuringiensis delta-endotoxins). Such an application may provide a broader spectrum of 33 plant protection and be advantageous for resistance management. The effect of the exogenously applied invertebrate pest control compounds of this invention may be synergistic with the expressed toxin proteins. General references for these agricultural protectants (i.e. insecticides, fungicides, 5 nematocides, acaricides, herbicides and biological agents) include The Pesticide Manual, 13th Edition, C. D. S. Tomlin, Ed., British Crop Protection Council, Farnham, Surrey, U.K., 2003 and The BioPesticide Manual, 2 Edition, L. G. Copping, Ed., British Crop Protection Council, Farnham, Surrey, U.K., 2001. For embodiments where one or more of these various mixing partners are used, the 10 weight ratio of these various mixing partners (in total) to the compound of Formula 1 is typically between about 1:3000 and about 3000:1. Of note are weight ratios between about 1:300 and about 300:1 (for example ratios between about 1:30 and about 30:1). One skilled in the art can easily determine through simple experimentation the biologically effective amounts of active ingredients necessary for the desired spectrum of biological activity. It 15 will be evident that including these additional components can expand the spectrum of invertebrate pests controlled beyond the spectrum controlled by the compound of Formula 1 alone. Table A lists specific combinations of a compound of Formula 1 with other invertebrate pest control agents illustrative of the mixtures, compositions and methods of the 20 present invention. The first column of Table A lists the specific invertebrate pest control agents (e.g., "Abamectin" in the first line). The second column of Table A lists the mode of action (if known) or chemical class of the invertebrate pest control agents. The third column of Table A lists embodiment(s) of ranges of weight ratios for rates at which the invertebrate pest control agent can be applied relative to a compound of Formula 1 (e.g., "50:1 to 1:50" 25 of abamectin relative to a compound of Formula 1 by weight). Thus, for example, the first line of Table A specifically discloses the combination of a compound of Formula 1 with abamectin can be applied in a weight ratio between 50:1 to 1:50. The remaining lines of Table A are to be construed similarly. Of further note Table A lists specific combinations of a compound of Formula 1 with other invertebrate pest control agents illustrative of the 30 mixtures, compositions and methods of the present invention and includes additional embodiments of weight ratio ranges for application rates. Table A Invertebrate Pest Mode of Action or Chemical Class Typical Control Agent Weight Ratio Abamectin macrocyclic lactones 50:1 to 1:50 Acetamiprid neonicotinoids 150:1 to 1:200 Amitraz octopamine receptor ligands 200:1 to 1:100 Avermectin macrocyclic lactones 50:1 to 1:50 34 Invertebrate Pest Mode of Action or Chemical Class Typical Control Agent Weight Ratio Azadirachtin ecdysone agonists 100:1 to 1:120 Beta-cyfluthrin sodium channel modulators 150:1 to 1:200 Bifenthrin sodium channel modulators 100:1 to 1:10 Buprofezin chitin synthesis inhibitors 500:1 to 1:50 Cartap nereistoxin analogs 100:1 to 1:200 Chlorantraniliprole ryanodine receptor ligands 100:1 to 1:120 Chlorfenapyr mitochondrial electron transport inhibitors 300:1 to 1:200 Chlorpyrifos cholinesterase inhibitors 500:1 to 1:200 Clothianidin neonicotinoids 100:1 to 1:400 Cyfluthrin sodium channel modulators 150:1 to 1:200 Cyhalothrin sodium channel modulators 150:1 to 1:200 Cypermethrin sodium channel modulators 150:1 to 1:200 Cyromazine chitin synthesis inhibitors 400:1 to 1:50 Deltamethrin sodium channel modulators 50:1 to 1:400 Dieldrin cyclodiene insecticides 200:1 to 1:100 Dinotefuran neonicotinoids 150:1 to 1:200 Diofenolan molting inhibitor 150:1 to 1:200 Emamectin macrocyclic lactones 50:1 to 1:10 Endosulfan cyclodiene insecticides 200:1 to 1:100 Esfenvalerate sodium channel modulators 100:1 to 1:400 Ethiprole GABA-regulated chloride channel 200:1 to 1:100 blockers Fenothiocarb 150:1 to 1:200 Fenoxycarb juvenile hormone mimics 500:1 to 1:100 Fenvalerate sodium channel modulators 150:1 to 1:200 Fipronil GABA-regulated chloride channel 150:1 to 1:100 blockers Flonicamid 200:1 to 1:100 Flubendiamide ryanodine receptor ligands 100:1 to 1:120 Flufenoxuron chitin synthesis inhibitors 200:1 to 1:100 Hexaflumuron chitin synthesis inhibitors 300:1 to 1:50 Hydramethylnon mitochondrial electron transport inhibitors 150:1 to 1:250 Imidacloprid neonicotinoids 1000:1 to 1:1000 Indoxacarb sodium channel modulators 200:1 to 1:50 Lambda-cyhalothrin sodium channel modulators 50:1 to 1:250 35 Invertebrate Pest Mode of Action or Chemical Class Typical Control Agent Weight Ratio Lufenuron chitin synthesis inhibitors 500:1 to 1:250 Metaflumizone 200:1 to 1:200 Methomyl cholinesterase inhibitors 500:1 to 1:100 Methoprene juvenile hormone mimics 500:1 to 1:100 Methoxyfenozide ecdysone agonists 50:1 to 1:50 Nitenpyram neonicotinoids 150:1 to 1:200 Nithiazine neonicotinoids 150:1 to 1:200 Novaluron chitin synthesis inhibitors 500:1 to 1:150 Oxamyl cholinesterase inhibitors 200:1 to 1:200 Pymetrozine 200:1 to 1:100 Pyrethrin sodium channel modulators 100:1 to 1:10 Pyridaben mitochondrial electron transport inhibitors 200:1 to 1:100 Pyridalyl 200:1 to 1:100 Pyriproxyfen juvenile hormone mimics 500:1 to 1:100 Ryanodine ryanodine receptor ligands 100:1 to 1:120 Spinetoram macrocyclic lactones 150:1 to 1:100 Spinosad macrocyclic lactones 500:1 to 1:10 Spirodiclofen lipid biosynthesis inhibitors 200:1 to 1:200 Spiromesifen lipid biosynthesis inhibitors 200:1 to 1:200 Tebufenozide ecdysone agonists 500:1 to 1:250 Thiacloprid neonicotinoids 100:1 to 1:200 Thiamethoxam neonicotinoids 1250:1 to 1:1000 Thiodicarb cholinesterase inhibitors 500:1 to 1:400 Thiosultap-sodium 150:1 to 1:100 Tralomethrin sodium channel modulators 150:1 to 1:200 Triazamate cholinesterase inhibitors 250:1 to 1:100 Triflumuron chitin synthesis inhibitors 200:1 to 1:100 Bacillus thuringiensis biological agents 50:1 to 1:10 Bacillus thuringiensis biological agents 50:1 to 1:10 delta-endotoxin NPV (e.g., Gemstar) biological agents 50:1 to 1:10 (a) ryanodine receptor ligands 100:1 to 1:120 (a) 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl] phenyl]-1H-pyrazole-5-carboxamide 36 Of note is the composition of the present invention wherein the at least one additional biologically active compound or agent is selected from the Invertebrate Pest Control Agents listed in Table A above. The weight ratios of a compound, including a compound of Formula 1 to the additional 5 invertebrate pest control agent typically are between 1000:1 and 1:1000, with one embodiment being between 500:1 and 1:500, another embodiment being between 250:1 and 1:200 and another embodiment being between 100:1 and 1:50. Listed below in Table B are embodiments of specific compositions comprising a compound of Formula 1 and an additional invertebrate pest control agent. 10 Table B Mixture No. Cmpd. and Invertebrate Pest Control Agent No. A-1 1 and Abamectin A-2 1 and Acetamiprid A-3 1 and Amitraz A-4 1 and Avermectin A-5 1 and Azadirachtin A-6 1 and Beta-cyfluthrin A-7 1 and Bifenthrin A-8 1 and Buprofezin A-9 1 and Cartap A-10 1 and Chlorantraniliprole A-11 1 and Chlorfenapyr A-12 1 and Chlorpyrifos A-13 1 and Clothianidin A-14 1 and Cyfluthrin A-15 1 and Cyhalothrin A-16 1 and Cypermethrin A-17 1 and Cyromazine A-18 1 and Deltamethrin A-19 1 and Dieldrin A-20 1 and Dinotefuran A-21 1 and Diofenolan A-22 1 and Emamectin A-23 1 and Endosulfan A-24 1 and Esfenvalerate A-25 1 and Ethiprole A-26 1 and Fenothiocarb 37 Mixture No. Cmpd. and Invertebrate Pest Control Agent No. A-27 1 and Fenoxycarb A-28 1 and Fenvalerate A-29 1 and Fipronil A-30 1 and Flonicamid A-31 1 and Flubendiamide A-32 1 and Flufenoxuron A-33 1 and Hexaflumuron A-34 1 and Hydramethylnon A-35 1 and Imidacloprid A-36 1 and Indoxacarb A-37 1 and Lambda-cyhalothrin A-38 1 and Lufenuron A-39 1 and Metaflumizone A-40 1 and Methomyl A-41 1 and Methoprene A-42 1 and Methoxyfenozide A-43 1 and Nitenpyram A-44 1 and Nithiazine A-45 1 and Novaluron A-46 1 and Oxamyl A-47 1 and Pymetrozine A-48 1 and Pyrethrin A-49 1 and Pyridaben A-50 1 and Pyridalyl A-51 1 and Pyriproxyfen A-52 1 and Ryanodine A-53 1 and Spinetoram A-54 1 and Spinosad A-55 1 and Spirodiclofen A-56 1 and Spiromesifen A-57 1 and Tebufenozide A-58 1 and Thiacloprid A-59 1 and Thiamethoxam A-60 1 and Thiodicarb A-61 1 and Thiosultap-sodium A-62 1 and Tralomethrin 38 Mixture No. Cmpd. and Invertebrate Pest Control Agent No. A-63 1 and Triazamate A-64 1 and Triflumuron A-65 1 and Bacillus thuringiensis A-66 1 and Bacillus thuringiensis delta-endotoxin A-67 1 and NPV (e.g., Gemstar) A-68 1 and (a) (a) 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl] phenyl]-1H-pyrazole-5-carboxamide The specific mixtures listed in Table B typically combine a compound of Formula 1 with the other invertebrate pest agent in the ratios specified in Table A. 5 Agronomic Application Invertebrate pests are controlled in agronomic and nonagronomic applications by applying the compound of this invention, typically in the form of a composition, in a biologically effective amount, to the environment of the pests, including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests 10 to be controlled. Thus the present invention comprises a method for controlling an invertebrate pest in agronomic and/or nonagronomic applications, comprising contacting the invertebrate pest or its environment with a biologically effective amount of one or more of the compounds of the invention, or with a composition comprising at least one such compound or a composition 15 comprising at least one such compound and a biologically effective amount of at least one additional biologically active compound or agent. Examples of suitable compositions comprising a compound of the invention and a biologically effective amount of at least one additional biologically active compound or agent include granular compositions wherein the additional active compound is present on the same granule as the compound of the invention 20 or on granules separate from those of the compound of the invention. To achieve contact with a compound or composition of the invention to protect a field crop from invertebrate pests, the compound or composition is typically applied to the seed of the crop before planting, to the foliage (e.g., leaves, stems, flowers, fruits) of crop plants, or to the soil or other growth medium before or after the crop is planted. 25 One embodiment of a method of contact is by spraying. Alternatively, a granular composition comprising a compound of the invention can be applied to the plant foliage or the soil. The compound of this invention can also be effectively delivered through plant uptake by contacting the plant with a composition comprising a compound of this invention applied as a soil drench of a liquid formulation, a granular formulation to the soil, a nursery 30 box treatment or a dip of transplants. Of note is a composition of the present invention in the 39 form of a soil drench liquid formulation. Also of note is a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of the present invention or with a composition comprising a biologically effective amount of a compound of the present invention. Of 5 further note is this method wherein the environment is soil and the composition is applied to the soil as a soil drench formulation. Of further note is that compounds of this invention are also effective by localized application to the locus of infestation. Other methods of contact include application of a compound or a composition of the invention by direct and residual sprays, aerial sprays, gels, seed coatings, microencapsulations, systemic uptake, baits, ear 10 tags, boluses, foggers, fumigants, aerosols, dusts and many others. One embodiment of a method of contact is a dimensionally stable fertilizer granule, stick or tablet comprising a compound or composition of the invention. The compound of this invention can also be impregnated into materials for fabricating invertebrate control devices (e.g., insect netting). Compound 1 of this invention is also useful in seed treatments for protecting seeds 15 from invertebrate pests. In the context of the present disclosure and claims, treating a seed means contacting the seed with a biologically effective amount of a compound of this invention, which is typically formulated as a composition of the invention. This seed treatment protects the seed from invertebrate soil pests and generally can also protect roots and other plant parts in contact with the soil of the seedling developing from the germinating 20 seed. The seed treatment may also provide protection of foliage by translocation of the compound of this invention or a second active ingredient within the developing plant. Seed treatments can be applied to all types of seeds, including those from which plants genetically transformed to express specialized traits will germinate. Representative examples include those expressing proteins toxic to invertebrate pests, such as Bacillus thuringiensis toxin or 25 those expressing herbicide resistance such as glyphosate acetyltransferase, which provides resistance to glyphosate. One method of seed treatment is by spraying or dusting the seed with a compound of the invention (i.e. as a formulated composition) before sowing the seeds. Compositions formulated for seed treatment generally comprise a film former or adhesive agent. Therefore 30 typically a seed coating composition of the present invention comprises a biologically effective amount of a compound of Formula 1 and a film former or adhesive agent. Seed can be coated by spraying a flowable suspension concentrate directly into a tumbling bed of seeds and then drying the seeds. Alternatively, other formulation types such as wetted powders, solutions, suspoemulsions, emulsifiable concentrates and emulsions in water can 35 be sprayed on the seed. This process is particularly useful for applying film coatings on seeds. Various coating machines and processes are available to one skilled in the art. Suitable processes include those listed in P. Kosters et al., Seed Treatment: Progress and Prospects, 1994 BCPC Mongraph No. 57, and references listed therein.
40 The treated seed typically comprises a compound of the present invention in an amount from about 0.1 g to 1 kg per 100 kg of seed (i.e. from about 0.0001 to 1% by weight of the seed before treatment). A flowable suspension formulated for seed treatment typically comprises from about 0.5 to about 70% of the active ingredient, from about 0.5 to about 30% 5 of a film-forming adhesive, from about 0.5 to about 20% of a dispersing agent, from 0 to about 5% of a thickener, from 0 to about 5% of a pigment and/or dye, from 0 to about 2% of an antifoaming agent, from 0 to about 1% of a preservative, and from 0 to about 75% of a volatile liquid diluent. Compound 1 of this invention can be incorporated into a bait composition that is 10 consumed by an invertebrate pest or used within a device such as a trap, bait station, and the like. Such a bait composition can be in the form of granules which comprise (a) active ingredients, namely a biologically effective amount of a compound of Formula 1, an N-oxide, or salt thereof; (b) one or more food materials; optionally (c) an attractant, and optionally (d) one or more humectants. Of note are granules or bait compositions which 15 comprise between about 0.001-5% active ingredients, about 40-99% food material and/or attractant; and optionally about 0.05-10% humectants, which are effective in controlling soil invertebrate pests at very low application rates, particularly at doses of active ingredient that are lethal by ingestion rather than by direct contact. Some food materials can function both as a food source and an attractant. Food materials include carbohydrates, proteins and lipids. 20 Examples of food materials are vegetable flour, sugar, starches, animal fat, vegetable oil, yeast extracts and milk solids. Examples of attractants are odorants and flavorants, such as fruit or plant extracts, perfume, or other animal or plant component, pheromones or other agents known to attract a target invertebrate pest. Examples of humectants, i.e. moisture retaining agents, are glycols and other polyols, glycerine and sorbitol. Of note is a bait 25 composition (and a method utilizing such a bait composition) used to control at least one invertebrate pest selected from the group consisting of ants, termites and cockroaches. A device for controlling an invertebrate pest can comprise the present bait composition and a housing adapted to receive the bait composition, wherein the housing has at least one opening sized to permit the invertebrate pest to pass through the opening so the invertebrate 30 pest can gain access to the bait composition from a location outside the housing, and wherein the housing is further adapted to be placed in or near a locus of potential or known activity for the invertebrate pest. Compound 1 of this invention can be applied without other adjuvants, but most often application will be of a formulation comprising one or more active ingredients with suitable 35 carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. One method of application involves spraying a water dispersion or refined oil solution of a compound of the present invention. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as 41 piperonyl butoxide often enhance compound efficacy. For nonagronomic uses such sprays can be applied from spray containers such as a can, a bottle or other container, either by means of a pump or by releasing it from a pressurized container, e.g., a pressurized aerosol spray can. Such spray compositions can take various forms, for example, sprays, mists, 5 foams, fumes or fog. Such spray compositions thus can further comprise propellants, foaming agents, etc. as the case may be. Of note is a spray composition comprising a biologically effective amount of a compound or a composition of the present invention and a carrier. One embodiment of such a spray composition comprises a biologically effective amount of a compound or a composition of the present invention and a propellant. 10 Representative propellants include, but are not limited to, methane, ethane, propane, butane, isobutane, butene, pentane, isopentane, neopentane, pentene, hydrofluorocarbons, chlorofluorocarbons, dimethyl ether, and mixtures of the foregoing. Of note is a spray composition (and a method utilizing such a spray composition dispensed from a spray container) used to control at least one invertebrate pest selected from the group consisting of 15 mosquitoes, black flies, stable flies, deer flies, horse flies, wasps, yellow jackets, hornets, ticks, spiders, ants, gnats, and the like, including individually or in combinations. Nongronomic and Animal Health Utility Nonagronomic uses refer to invertebrate pest control in the areas other than fields of crop plants. Nonagronomic uses of the present compounds and compositions include control 20 of invertebrate pests in stored grains, beans and other foodstuffs, and in textiles such as clothing and carpets. Nonagronomic uses of the present compounds and compositions also include invertebrate pest control in ornamental plants, forests, in yards, along roadsides and railroad rights of way, and on turf such as lawns, golf courses and pastures. Nonagronomic uses of the present compounds and compositions also include invertebrate pest control in 25 houses and other buildings which may be occupied by humans and/or companion, farm, ranch, zoo or other animals. Nonagronomic uses of the present compound and compositions also include the control of pests such as termites that can damage wood or other structural materials used in buildings. Nonagronomic uses of the present Compound 1 and compositions also include 30 protecting human and animal health by controlling invertebrate pests that are parasitic or transmit infectious diseases. The controlling of animal parasites includes controlling external parasites that are parasitic to the surface of the body of the host animal (e.g., shoulders, armpits, abdomen, inner part of the thighs) and internal parasites that are parasitic to the inside of the body of the host animal (e.g., stomach, intestine, lung, veins, under the 35 skin, lymphatic tissue). External parasitic or disease transmitting pests include, for example, chiggers, ticks, lice, mosquitoes, flies, mites and fleas. Internal parasites include heartworms, hookworms and helminths. Compounds and compositions of the present invention are particularly suitable for combating external parasitic or disease transmitting 42 pests. Compound 1 and compositions of the present invention are suitable for systemic and/or non-systemic control of infestation or infection by parasites on animals. Compound 1 and compositions of the present invention are suitable for combating parasites that infest animal subjects including those in the wild, livestock and agricultural 5 working animals such as cattle, sheep, goats, horses, pigs, donkeys, camels, buffalos, rabbits, hens, turkeys, ducks, geese and bees (e.g., raised for meat, milk, butter, eggs, fur, leather, feathers and/or wool). By combating parasites, fatalities and performance reduction (in terms of meat, milk, wool, skins, eggs, honey, etc.) are reduced, so that applying a composition comprising a compound of the present invention allows more economic and 10 simple husbandry of animals. Compound 1 and compositions of the present invention are especially suitable for combating parasites that infest companion animals and pets (e.g., dogs, cats, pet birds and aquarium fish), research and experimental animals (e.g., hamsters, guinea pigs, rats and mice), as well as animals raised for/in zoos, wild habitats and/or circuses. 15 In an embodiment of this invention, the animal is preferably a vertebrate, and more preferably a mammal, avian or fish. In a particular embodiment, the animal subject is a mammal (including great apes, such as humans). Other mammalian subjects include primates (e.g., monkeys), bovine (e.g., cattle or dairy cows), porcine (e.g., hogs or pigs), ovine (e.g., goats or sheep), equine (e.g., horses), canine (e.g., dogs), feline (e.g., house cats), 20 camels, deer, donkeys, buffalos, antelopes, rabbits, and rodents (e.g., guinea pigs, squirrels, rats, mice, gerbils, and hamsters). Avians include Anatidae (swans, ducks and geese), Columbidae (e.g., doves and pigeons), Phasianidae (e.g., partridges, grouse and turkeys), Thesienidae (e.g., domestic chickens), Psittacines (e.g., parakeets, macaws, and parrots), game birds, and ratites (e.g., ostriches). 25 Birds treated or protected by the inventive compounds can be associated with either commercial or noncommercial aviculture. These include Anatidae, such as swans, geese, and ducks, Columbidae, such as doves and domestic pigeons, Phasianidae, such as partridge, grouse and turkeys, Thesienidae, such as domestic chickens, and Psittacines, such as parakeets, macaws, and parrots raised for the pet or collector market, among others. 30 For purposes of the present invention, the term "fish" shall be understood to include without limitation, the Teleosti grouping of fish, i.e., teleosts. Both the Salmoniformes order (which includes the Salmonidae family) and the Perciformes order (which includes the Centrarchidae family) are contained within the Teleosti grouping. Examples of potential fish recipients include the Salmonidae, Serranidae, Sparidae, Cichlidae, and Centrarchidae, 35 among others. Other animals are also contemplated to benefit from the inventive methods, including marsupials (such as kangaroos), reptiles (such as farmed turtles), and other economically 43 important domestic animals for which the inventive methods are safe and effective in treating or preventing parasite infection or infestation. Animal Health Pests/Parasites Examples of invertebrate parasitic pests controlled by administering a parasiticidally 5 effective amount of a compound of this invention to an animal to be protected include ectoparasites (arthropods, acarines, etc) and endoparasites (helminths, e.g., nematodes, trematodes, cestodes, acanthocephalans, etc.). The disease or group of diseases described generally as helminthiasis is due to infection of an animal host with parasitic worms known as helminths. The term 'helminths' 10 is meant to include nematodes, trematodes, cestodes and acanthocephalans. Helminthiasis is a prevalent and serious economic problem with domesticated animals such as swine, sheep, horses, cattle, goats, dogs, cats and poultry. Among the Helminths, the group of worms described as nematodes causes widespread and at times serious infection in various species of animals. Nematodes that are 15 contemplated to be treated by the compounds of this invention and by the inventive methods include, without limitation, the following genera: Acanthocheilonema, Aelurostrongylus, Ancylostoma, Angiostrongylus, Ascaridia, Ascaris, Brugia, Bunostomum, Capillaria, Chabertia, Cooperia, Crenosoma, Dictyocaulus, Dioctophyme, Dipetalonema, Diphyllobothrium, Dirofilaria, Dracunculus, Enterobius, Filaroides, Haemonchus, Heterakis, 20 Lagochilascaris, Loa, Mansonella, Muellerius, Necator, Nematodirus, Oesophagostomum, Ostertagia, Oxyuris, Parafilaria, Parascaris, Physaloptera, Protostrongylus, Setaria, Spirocerca, Stephanofilaria, Strongyloides, Strongylus, Thelazia, Toxascaris, Toxocara, Trichinella, Trichonema, Trichostrongylus, Trichuris, Uncinaria, and Wuchereria. Of the above, the most common genera of nematodes infecting the animals referred to 25 above are Haemonchus, Trichostrongylus, Ostertagia, Nematodirus, Cooperia, Ascaris, Bunostomum, Oesophagostomum, Chabertia, Trichuris, Strongylus, Trichonema, Dictyocaulus, Capillaria, Heterakis, Toxocara, Ascaridia, Oxyuris, Ancylostoma, Uncinaria, Toxascaris and Parascaris. Certain of these, such as Nematodirus, Cooperia and Oesophagostomum attack primarily the intestinal tract while others, such as Haemonchus 30 and Ostertagia, are more prevalent in the stomach while others such as Dictyocaulus are found in the lungs. Still other parasites may be located in other tissues such as the heart and blood vessels, subcutaneous and lymphatic tissue and the like. Trematodes that are contemplated to be treated by the Compound 1 of this invention and by the inventive methods include, without limitation, the following genera: Alaria, 35 Fasciola, Nanophyetus, Opisthorchis, Paragonimus and Schistosoma. Cestodes that are contemplated to be treated by the Compound 1 of this invention and by the inventive methods include, without limitation, the following genera: Diphyllobothrium, Diplydium, Spirometra and Taenia.
44 The most common genera of parasites of the gastrointestinal tract of humans are Ancylostoma, Necator, Ascaris, Strongyloides, Trichinella, Capillaria, Trichuris, and Enterobius. Other medically important genera of parasites which are found in the blood or other tissues and organs outside the gastrointestinal tract are the filarial worms such as 5 Wuchereria, Brugia, Onchocerca and Loa, as well as Dracunculus and extra intestinal stages of the intestinal worms Strongyloides and Trichinella. Numerous other Helminth genera and species are known to the art, and are also contemplated to be treated by the compounds of the invention. These are enumerated in great detail in Textbook of Veterinary Clinical Parasitology, Volume 1, Helminths, E. J. L. 10 Soulsby, F. A. Davis Co., Philadelphia, Pa.; Helminths, Arthropods and Protozoa, (6th Edition of Monnig's Veterinary Helminthology and Entomology), E. J. L. Soulsby, The Williams and Wilkins Co., Baltimore, Md. It is also contemplated that the inventive compound is effective against a number of ectoparasites of animals, e.g., arthropod ectoparasites of mammals and birds although it is 15 also recognized that some arthropods can be endoparasites as well. Thus, insect and acarine pests include, e.g., biting insects, such as flies and mosquitoes, mites, ticks, lice, fleas, true bugs, parasitic maggots, and the like. Adult flies include, e.g., the horn fly or Haematobia irritans, the horse fly or Tabanus spp., the stable fly or Stomoxys calcitrans, the black fly or Simulium spp., the deer fly or 20 Chrysops spp., the louse fly or Melophagus ovinus, the tsetse fly or Glossina spp. Parasitic fly maggots include, e.g., the bot fly (Oestrus ovis and Cuterebra spp.), the blow fly or Phaenicia spp., the screwworm or Cochliomyia hominivorax, the cattle grub or Hypoderma spp., the fleeceworm and the Gastrophilus of horses. Mosquitoes include, for example, Culex spp., Anopheles spp., and Aedes spp. 25 Mites include Mesostigmata spp. e.g., mesostigmatids such as the chicken mite, Dermanyssus gallinae; itch or scab mites such as Sarcoptidae spp. for example, Sarcoptes scabiei; mange mites such as Psoroptidae spp. including Chorioptes bovis and Psoroptes ovis; chiggers e.g., Trombiculidae spp. for example the North American chigger, Trombicula alfreddugesi. 30 Ticks include, e.g., soft-bodied ticks including Argasidae spp. for example Argas spp. and Ornithodoros spp.; hard-bodied ticks including Ixodidae spp., for example Rhipicephalus sanguineus, Dermacentor variabilis, Dermacentor andersoni, Amblyomma americanum, Ixodes scapularis and Boophilus spp. Lice include, e.g., sucking lice, e.g., Menopon spp. and Bovicola spp.; biting lice, e.g., 35 Haematopinus spp., Linognathus spp. and Solenopotes spp. Fleas include, e.g., Ctenocephalides spp., such as dog flea (Ctenocephalides canis) and cat flea (Ctenocephalides felis); Xenopsylla spp. such as oriental rat flea (Xenopsylla cheopis); and Pulex spp. such as human flea (Pulex irritans).
45 True bugs include, e.g., Cimicidae or e.g., the common bed bug (Cimex lectularius); Triatominae spp. including triatomid bugs also known as kissing bugs; for example Rhodnius prolixus and Triatoma spp. Generally, flies, fleas, lice, mosquitoes, gnats, mites, ticks and helminths cause 5 tremendous losses to the livestock and companion animal sectors. Arthropod parasites also are a nuisance to humans and can vector disease-causing organisms in humans and animals. Numerous other arthropod pests and ectoparasites are known to the art, and are also contemplated to be treated by Compound 1 of the invention. These are enumerated in great detail in Medical and Veterinary Entomology, D. S. Kettle, John Wiley & Sons, New York 10 and Toronto; Control of Arthropod Pests of Livestock: A Review of Technology, R. 0. Drummand, J. E. George, and S. E. Kunz, CRC Press, Boca Raton, Fla. It is also contemplated that Compound 1 and compositions of this invention may be effective against a number of protozoa endoparasites of animals, including those summarized by Table 3, as follows. 15 Table 3 Exemplary Parasitic Protozoa and Associated Human Diseases Representative Genera Human Disease or Phylum Subphylum Disorder Sarcomastigophora Mastigophora Leishmania Visceral, cutaneous (with flagella, (Flagella) and mucocutaneous pseudopodia, or Infection both) Trypansoma Sleeping sickness Chagas' disease Giardia Diarrhea Trichomonas Vaginitis Sarcodina Entamoeba Dysentery, liver (pseudopodia) Abscess Dientamoeba Colitis Naegleria and Central nervous Acanthamoeba system and corneal ulcers Babesia Babesiesis Apicomplexa Plasmodium Malaria (apical complex) Isospora Diarrhea Sarcocystis Diarrhea 46 Cryptosporidum Diarrhea Toxoplasma Toxoplasmosis Eimeria Chicken coccidiosis Microspora Enterocytozoon Diarrhea Ciliaphora (with Balantidium Dysentery cilia) Unclassified Pneumocystis Pneumonia In particular, Compound 1 of this invention is effective against ectoparasites including: flies such as Haematobia (Lyperosia) irritans (horn fly), Stomoxys calcitrans (stable fly), Simulium spp. (blackfly), Glossina spp. (tsetse flies), Hydrotaea irritans (head fly), Musca 5 autumnalis (face fly), Musca domestica (house fly), Morellia simplex (sweat fly), Tabanus spp. (horse fly), Hypoderma bovis, Hypoderma lineatum, Lucilia sericata, Lucilia cuprina (green blowfly), Calliphora spp. (blowfly), Protophormia spp., Oestrus ovis (nasal botfly), Culicoides spp. (midges), Hippobosca equine, Gastrophilus instestinalis, Gastrophilus haemorrhoidalis and Gastrophilus naslis; lice such as Bovicola (Damalinia) bovis, Bovicola 10 equi, Haematopinus asini, Felicola subrostratus, Heterodoxus spiniger, Lignonathus setosus and Trichodectes canis; keds such as Melophagus ovinus; mites such as Psoroptes spp., Sarcoptes scabei, Chorioptes bovis, Demodex equi, Cheyletiella spp., Notoedres cati, Trombicula spp. and Otodectes cyanotis (ear mites); ticks such as Ixodes spp., Boophilus spp., Rhipicephalus spp., Amblyomma spp., Dermacentor spp., Hyalomma spp. and 15 Haemaphysalis spp.; and fleas such as Ctenocephalides felis (cat flea) and Ctenocephalides canis (dog flea). Animal Health Mixtures Biologically active Compound 1 or agents useful in the compositions of the present invention include the organophosphate pesticides. This class of pesticides has very broad 20 activity as insecticides and, in certain instances, anthelminitic activity. Organophosphate pesticides include, e.g., dicrotophos, terbufos, dimethoate, diazinon, disulfoton, trichlorfon, azinphos-methyl, chlorpyrifos, malathion, oxydemeton-methyl, methamidophos, acephate, ethyl parathion, methyl parathion, mevinphos, phorate, carbofenthion and phosalone. It is also contemplated to include combinations of the inventive methods and compounds with 25 carbamate type pesticides, including, e.g., carbaryl, carbofuran, aldicarb, molinate, methomyl, carbofuran, etc., as well as combinations with the organochlorine type pesticides. It is further contemplated to include combinations with biological pesticides, including repellents, the pyrethrins (as well as synthetic variations thereof, e.g., allethrin, resmethrin, permethrin, tralomethrin), and nicotine, that is often employed as an acaricide. Other 30 contemplated combinations are with miscellaneous pesticides including: bacillus thuringensis, chlorobenzilate, formamidines (e.g., amitraz), copper compounds (e.g., copper 47 hydroxide and cupric oxychloride sulfate), cyfluthrin, cypermethrin, dicofol, endosulfan, esenfenvalerate, fenvalerate, lambda-cyhalothrin, methoxychlor and sulfur. Of note are additional biologically active compounds or agents selected from art known anthelmintics, such as, for example, avennectins (e.g., ivennectin, moxidectin, 5 milbemycin), benzimidazoles (e.g., albendazole, triclabendazole), salicylanilides (e.g., closantel, oxyclozanide), substituted phenols (e.g., nitroxynil), pyrimidines (e.g., pyrantel), imidazothiazoles (e.g., levamisole) and praziquantel. Other biologically active compounds or agents useful in the compositions of the present invention can be selected from Insect Growth Regulators (IGRs) and Juvenile 10 Hormone Analogues (JHAs) such as diflubenzuron, triflumuron, fluazuron, cyromazine, methoprene, etc., thereby providing both initial and sustained control of parasites (at all stages of insect development, including eggs) on the animal subject, as well as within the environment of the animal subject. Of note are biologically active compounds or agents useful in the compositions of the 15 present invention selected from the antiparasitic class of avennectin compounds. As stated above, the avermectin family of compounds is a series of very potent antiparasitic agents known to be useful against a broad spectrum of endoparasites and ectoparasites in mammals. A preferred compound for use within the scope of the present invention is ivermectin. Ivennectin is a semi-synthetic derivative of avermectin and is generally produced as a 20 mixture of at least 80% 22,23-Dihydroavermectin Bia and less than 20% 22,23 Dihydroavennectin Bib. Ivennectin is disclosed in U.S. 4,199,569. Abamectin is an avermectin that is disclosed as Avermectin Bla/Blb in U.S. 4,310,519. Abamectin contains at least 80% of avennectin B la and not more than 20% of avermectin Bib 25 Another preferred avermectin is Doramectin, also known as 25-Cyclohexyl-avennectin
B
1 . The structure and preparation of Doramectin is disclosed in U.S. 5,089,480. Another preferred avennectin is Moxidectin. Moxidectin, also known as LL-F28249 alpha, is known from U.S. 4,916,154. Another preferred avermectin is Selamectin. Selamectin is 25-Cyclohexyl-25-de(1 30 methylpropyl)-5-deoxy-22,23-dihydro-5-(hydroxyimino)-avennectin B I monosaccharide. Milbemycin, or B41, is a substance which is isolated from the fermentation broth of a Milbemycin producing strain of Streptomyces. The microorganism, the fermentation conditions and the isolation procedures are more fully described in U.S. 3,950,360 and U.S. 3,984,564. 35 Emamectin (4"-deoxy-4"-epi-Methylaminoavennectin B 1), which can be prepared as described in U.S. 5,288,710 or U.S. 5,399,717, is a mixture of two homologues, 4"-deoxy 4"-epi-methylaminoavermectin Bla and 4"-deoxy-4"-epi-methylaminoavermectin Blb Preferably, a salt of Emamectin is used. Non-limiting examples of salts of Emamectin which 48 may be used in the present invention include the salts described in U.S. 5,288,710, e.g., salts derived from benzoic acid, substituted benzoic acid, benzenesulfonic acid, citric acid, phosphoric acid, tartaric acid, maleic acid, and the like. Most preferably, the Emamectin salt used in the present invention is Emamectin benzoate. 5 Eprinomectin is chemically known as 4"-epi-acetylamino-4"-deoxy-avermectin B 1 . Eprinomectin was specifically developed to be used in all cattle classes and age groups. It was the first avermectin to show broad-spectrum activity against both endo- and ecto parasites while also leaving minimal residues in meat and milk. It has the additional advantage of being highly potent when delivered topically. 10 The composition of the present invention optionally comprises combinations of one or more of the following antiparasite compounds: imidazo[1,2-b]pyridazine compounds as described by U.S. application Ser. No. 11/019,597, filed on Dec. 22, 2004; 1-(4-mono and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanol compounds, as described by U.S. application Ser. No. 11/018,156, filed on Dec. 21, 2004; trifluoromethanesulfonanilide 15 oxime ether derivatives, as described by U.S. application Ser. No. 11/231,423, filed on Sep. 21, 2005; and n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n [(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives, as described by U.S. Provisional Application Ser. No. 60/688,898, filed on Jun. 9, 2005. The compositions of the present invention may also further comprise a flukicide. 20 Suitable flukicides include, for example, Triclabendazole, Fenbendazole, Albendazole, Clorsulon and Oxibendazole. It will be appreciated that the above combinations may further include combinations of antibiotic, antiparasitic and anti-fluke active compounds. In addition to the above combinations, it is also contemplated to provide combinations of the inventive methods and compounds, as described herein, with other animal health 25 remedies such as trace elements, anti-inflammatories, anti-infectives, hormones, dermatological preparations, including antiseptics and disinfectants, and immunobiologicals such as vaccines and antisera for the prevention of disease. For example, such antinfectives include one or more antibiotics that are optionally co administered during treatment using the inventive compounds or methods, e.g., in a 30 combined composition and/or in separate dosage forms. Art-known antibiotics suitable for this purpose include, for example, those listed herein below. One useful antibiotic is Florfenicol, also known as D-(threo)-1-(4 methylsulfonylphenyl)-2-dichloroacetamido-3-fluoro-1-propanol. Another preferred antibiotic compound is D-(threo)-1-(4-methylsulfonyphenyl)-2-difluoroacetamido-3-fluoro 35 1-propanol. Another useful antibiotic is Thiamphenicol. Processes for the manufacture of these antibiotic compounds, and intermediates useful in such processes, are described in U.S. 4,311,857; U.S. 4,582,918; U.S. 4,973,750; U.S. 4,876,352; U.S. 5,227,494; U.S. 4,743,700; U.S. 5,567,844; U.S. 5,105,009; U.S. 5,382,673; U.S. 5,352,832; and U.S. 5,663,361. Other 49 florfenicol analogs and/or prodrugs have been disclosed and such analogs also can be used in the compositions and methods of the present invention (see e.g., U.S. Patent Application Publication No: 2004/0082553, and U.S. patent application Ser. No. 11/016,794). Another useful antibiotic compound is Tilmicosin. Tilmicosin is a macrolide antibiotic 5 that is chemically defined as 20-dihydro-20-deoxy-20-(cis-3,5 -dimethylpiperidin- 1-yl) desmycosin and which is reportedly disclosed in U.S. 4,820,695. Another useful antibiotic for use in the present invention is Tulathromycin. Tulathromycin may be identified as 1 -oxa-6-azacyclopentadecan- 15-one, 13-[(2,6-dideoxy 3-C-methyl-3-0-methyl-4-C-[(propylamino)methyl]-alpha-L--ribo-hexopyranosyl]oxy]-2 10 ethyl-3,4, 10-trihydroxy-3,5,8,10,12,14-hexamethy- 1-11-[[3,4,6-trideoxy-3-(dimethylamino) beta-D-xylo-hexopyranosyl]oxy]-, (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R). Tulathromycin may be prepared in accordance with the procedures set forth in U.S. Patent Publication No. 2003/0064939 Al. Further antibiotics for use in the present invention include the cephalosporins such as, 15 for example, Ceftiofur, Cefquinome, etc. The concentration of the cephalosporin in the formulation of the present invention optionally varies between about 1 mg/ml to 500 mg/ml. Another useful antibiotic includes the fluoroquinolones, such as, for example, Enrofloxacin, Danofloxacin, Difloxacin, Orbifloxacin and Marbofloxacin. In the case of Enrofloxacin, it may be administered in a concentration of about 100 mg/ml. Danofloxacin 20 may be present in a concentration of about 180 mg/ml. Other useful macrolide antibiotics include compounds from the class of ketolides, or, more specifically, the azalides. Such compounds are described in, for example, U.S. 6,514,945, U.S. 6,472,371, U.S. 6,270,768, U.S. 6,437,151, U.S. 6,271,255, U.S. 6,239,112, U.S. 5,958,888, U.S. 6,339,063 and U.S. 6,054,434. 25 Other useful antibiotics include the tetracyclines, particularly Chlortetracycline and Oxytetracycline. Other antibiotics may include B-lactams such as penicillins, e.g., Penicillin, Ampicillin, Amoxicillin, or a combination of Amoxicillin with Clavulanic acid or other beta lactamase inhibitors. Animal Health Formulation/Application 30 Nonagronomic applications in the veterinary sector are by conventional means such as by enteral administration in the form of, for example, tablets, capsules, drinks, drenching preparations, granulates, pastes, boli, feed-through procedures, or suppositories; or by parenteral administration, such as by injection (including intramuscular, subcutaneous, intravenous, intraperitoneal) or implants; by nasal administration; by topical administration, 35 for example, in the form of immersion or dipping, spraying, washing, coating with powder, or application to a small area of the animal, and through articles such as neck collars, ear tags, tail bands, limb bands or halters which comprise compounds or compositions of the present invention.
50 Compound 1 of the present invention, or a suitable combination of such compound, may be administered directly to the animal subject and/or indirectly by applying it to the local environment in which the animal dwells (such as bedding, enclosures, or the like). Direct administration includes contacting the skin, fur or feathers of a subject animal with 5 the compound, or by feeding or injecting the compound into the animal. Compound 1 of the present invention may be administered in a controlled release form, e.g., in a subcutaneous slow release formulation, or in the form of a controlled release device affixed to an animal such as a fleacollar. Collars for the controlled release of an insecticide agent for long term protection against flea infestation in a companion animal are 10 art-known, and are described, for example, by U.S. 3,852,416, U.S. 4,224,901, U.S. 5,555,848 and U.S. 5,184,573. Typically a parasiticidal composition according to the present invention comprises a mixture of a compound of Formula 1 with one or more pharmaceutically or veterinarily acceptable carriers comprising excipients and auxiliaries selected with regard to the intended 15 route of administration (e.g., oral, topical or parenteral administration such as injection) and in accordance with standard practice. In addition, a suitable carrier is selected on the basis of compatibility with the one or more active ingredients in the composition, including such considerations as stability relative to pH and moisture content. Therefore of note is a composition for protecting an animal from an invertebrate parasitic pest comprising a 20 parasitically effective amount of a compound of the invention and at least one carrier. For parenteral administration including intravenous, intramuscular and subcutaneous injection, a compound of the present invention can be formulated in suspension, solution or emulsion in oily or aqueous vehicles, and may contain adjuncts such as suspending, stabilizing and/or dispersing agents. The compounds of the present invention may also be 25 formulated for bolus injection or continuous infusion. Pharmaceutical compositions for injection include aqueous solutions of water-soluble forms of active ingredients (e.g., a salt of an active compound), preferably in physiologically compatible buffers containing other excipients or auxiliaries as are known in the art of pharmaceutical formulation. Additionally, suspensions of the active compound may be prepared in a lipophilic vehicle. 30 Suitable lipophilic vehicles include fatty oils such as sesame oil, synthetic fatty acid esters such as ethyl oleate and triglycerides, or materials such as liposomes. Aqueous injection suspensions may contain substances that increase the viscosity of the suspension, such as sodium carboxymethyl cellulose, sorbitol, or dextran. Formulations for injection may be presented in unit dosage form, e.g., in ampoules or in multi-dose containers. Alternatively, 35 the active ingredient may be in powder form for constitution with a suitable vehicle, e.g., sterile, pyrogen-free water, before use. In addition to the formulations described supra, Compound 1 of the present invention may also be formulated as a depot preparation. Such long acting formulations may be 51 administered by implantation (for example, subcutaneously or intramuscularly) or by intramuscular or subcutaneous injection. Compound 1 of the present invention may be formulated for this route of administration with suitable polymeric or hydrophobic materials (for instance, in an emulsion with a pharmacologically acceptable oil), with ion exchange 5 resins, or as a sparingly soluble derivative such as, without limitation, a sparingly soluble salt. For administration by inhalation, Compound 1 of the present invention can be delivered in the form of an aerosol spray using a pressurized pack or a nebulizer and a suitable propellant, e.g., without limitation, dichlorodifluoromethane, 10 trichlorofluoromethane, dichlorotetrafluoroethane or carbon dioxide. In the case of a pressurized aerosol, the dosage unit may be controlled by providing a valve to deliver a metered amount. Capsules and cartridges of, for example, gelatin for use in an inhaler or insufflator may be formulated containing a powder mix of the compound and a suitable powder base such as lactose or starch. 15 Compound 1 of the present invention has been discovered to have favorable pharmacokinetic and pharmacodynamic properties providing systemic availability from oral administration and ingestion. Therefore after ingestion by the animal to be protected, parasiticidally effective concentrations of compounds of the invention in the bloodstream protect the treated animal from blood-sucking pests such as fleas, ticks and lice. Therefore 20 of note is a composition for protecting an animal from an invertebrate parasite pest in a form for oral administration (i.e. comprising, in addition to a parasiticidally effective amount of a compound of the invention, one or more carriers selected from binders and fillers suitable for oral administration and feed concentrate carriers). For oral administration in the form of solutions (the most readily available form for 25 absorption), emulsions, suspensions, pastes, gels, capsules, tablets, boluses, powders, granules, rumen-retention and feed/water/lick blocks, a compound of the present invention can be formulated with binders/fillers known in the art to be suitable for oral administration compositions, such as sugars and sugar derivatives (e.g., lactose, sucrose, mannitol, sorbitol), starch (e.g., maize starch, wheat starch, rice starch, potato starch), cellulose and derivatives 30 (e.g., methylcellulose, carboxymethylcellulose, ethylhydroxycellulose), protein derivatives (e.g., zein, gelatin), and synthetic polymers (e.g., polyvinyl alcohol, polyvinylpyrrolidone). If desired, lubricants (e.g., magnesium stearate), disintegrating agents (e.g., cross-linked polyvinylpyrrolidinone, agar, alginic acid) and dyes or pigments can be added. Pastes and gels often also contain adhesives (e.g., acacia, alginic acid, bentonite, cellulose, xanthan 35 gum, colloidal magnesium aluminum silicate) to aid in keeping the composition in contact with the oral cavity and not being easily ejected. If the parasiticidal compositions are in the form of feed concentrates, the carrier is typically selected from high-performance feed, feed cereals or protein concentrates. Such 52 feed concentrate-containing compositions can, in addition to the parasiticidal active ingredients, comprise additives promoting animal health or growth, improving quality of meat from animals for slaughter or otherwise useful to animal husbandry. These additives can include, for example, vitamins, antibiotics, chemotherapeutics, bacteriostats, fungistats, 5 coccidiostats and hormones. The compound of Formula 1 may also be formulated in rectal compositions such as suppositories or retention enemas, using, e.g., conventional suppository bases such as cocoa butter or other glycerides. Formulations for topical administration are typically in the form of a powder, cream, 10 suspension, spray, emulsion, foam, paste, aerosol, ointment, salve or gel. More typically a topical formulation is a water-soluble solution, which can be in the form of a concentrate that is diluted before use. Parasiticidal compositions suitable for topical administration typically comprise a compound of the present invention and one or more topically suitable carriers. In applications of a parasiticidal composition topically to the exterior of an animal as a line or 15 spot (i.e. "spot-on" treatment), the active ingredient migrates over the surface of the animal to cover most or all of its external surface area. As a result, the treated animal is particularly protected from invertebrate pests that feed off the epidermis of the animal such as ticks, fleas and lice. Therefore formulations for topical localized administration often comprise at least one organic solvent to facilitate transport of the active ingredient over the skin and/or 20 penetration into the epidermis of the animal. Carriers in such formulations include propylene glycol, paraffins, aromatics, esters such as isopropyl myristate, glycol ethers, alcohols such as ethanol, n-propanol, 2-octyl dodecanol or oleyl alcohol; solutions in esters of monocarboxylic acids, such as isopropyl myristate, isopropyl palmitate, lauric acid oxalic ester, oleic acid oleyl ester, oleic acid decyl ester, hexyl laurate, oleyl oleate, decyl oleate, 25 caproic acid esters of saturated fatty alcohols of chain length C 12
-C
18 ; solutions of esters of dicarboxylic acids, such as dibutyl phthalate, diisopropyl isophthalate, adipic acid diisopropyl ester, di-n-butyl adipate or solutions of esters of aliphatic acids, e.g., glycols. It may be advantageous for a crystallization inhibitor or a dispersant known from the pharmaceutical or cosmetic industry also to be present. 30 A pour-on formulation may also be prepared for control of parasites in an animal of agricultural worth. The pour-on formulations of this invention can be in the form of a liquid, powder, emulsion, foam, paste, aerosol, ointment, salve or gel. Typically, the pour-on formulation is liquid. These pour-on formulations can be effectively applied to sheep, cattle, goats, other ruminants, camelids, pigs and horses. The pour-on formulation is typically 35 applied by pouring in one or several lines or in a spot-on the dorsal midline (back) or shoulder of an animal. More typically, the formulation is applied by pouring it along the back of the animal, following the spine. The formulation can also be applied to the animal by other conventional methods, including wiping an impregnated material over at least a small 53 area of the animal, or applying it using a commercially available applicator, by means of a syringe, by spraying or by using a spray race. The pour-on formulations include a carrier and can also include one or more additional ingredients. Examples of suitable additional ingredients are stabilizers such as antioxidants, spreading agents, preservatives, adhesion 5 promoters, active solubilisers such as oleic acid, viscosity modifiers, UV blockers or absorbers, and colourants. Surface active agents, including anionic, cationic, non-ionic and ampholytic surface active agents, can also be included in these formulations. The formulations of this invention typically include an antioxidant, such as BHT (butylated hydroxytoluene). The antioxidant is generally present in amounts of at 0.1-5% 10 (wt/vol). Some of the formulations require a solubilizer, such as oleic acid, to dissolve the active agent, particularly if spinosad is used. Common spreading agents used in these pour on formulations are: IPM, IPP, caprylic/capric acid esters of saturated C 12
-C
18 fatty alcohols, oleic acid, oleyl ester, ethyl oleate, triglycerides, silicone oils and DPM. The pour-on formulations of this invention are prepared according to known techniques. Where the pour 15 on is a solution, the parasiticide/insecticide is mixed with the carrier or vehicle, using heat and stirring where required. Auxiliary or additional ingredients can be added to the mixture of active agent and carrier, or they can be mixed with the active agent prior to the addition of the carrier. If the pour-on is an emulsion or suspension, these formulations are similarly prepared using known techniques. 20 Other delivery systems for relatively hydrophobic pharmaceutical compounds may be employed. Liposomes and emulsions are well-known examples of delivery vehicles or carriers for hydrophobic drugs. In addition, organic solvents such as dimethylsulfoxide may be used, if needed. For agronomic applications, the rate of application required for effective control (i.e. 25 "biologically effective amount") will depend on such factors as the species of invertebrate to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredients per hectare are sufficient to control pests in agronomic ecosystems, but as little as 30 0.0001 kg/hectare may be sufficient or as much as 8 kg/hectare may be required. For nonagronomic applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required. One skilled in the art can easily determine the biologically effective amount necessary for the desired level of invertebrate pest control. 35 In general for veterinary use, a compound of Formula 1 is administered in a parasiticidally effective amount to an animal to be protected from invertebrate parasite pests. A parasiticidally effective amount is the amount of active ingredient needed to achieve an observable effect diminishing the occurrence or activity of the target invertebrate parasite 54 pest. One skilled in the art will appreciate that the parasitically effective dose can vary for the various compounds and compositions of the present invention, the desired parasitical effect and duration, the target invertebrate pest species, the animal to be protected, the mode of application and the like, and the amount needed to achieve a particular result can be 5 determined through simple experimentation. For oral administration to homeothermic animals, the daily dosage of Compound 1 of the present invention typically ranges from about 0.01 mg/kg to about 100 mg/kg, more typically from about 0.5 mg/kg to about 100 mg/kg, of animal body weight. For topical (e.g., dermal) administration, dips and sprays typically contain from about 0.5 ppm to about 10 5000 ppm, more typically from about 1 ppm to about 3000 ppm, of Compound 1 of the present invention. Further, any prior art reference or statement provided in the specification is not to be taken as an admission that such art constitutes, or is to be understood as constituting, part of the common general knowledge in Australia.

Claims (9)

1. A crystalline polymorph of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5 dihydro-5 -(trifluoromethyl)-3 -isoxazolyl] -N- [2-oxo-2- [(2,2,2-trifluoroethyl)amino] ethyl] -1 5 naphthalenecarboxamide designated Form B characterized by a powder X-ray diffraction pattern having at least the 2 reflection positions 2
17.433
18.586
20.207 20.791
21.41
22.112
23.182
24.567
27.844 2. A composition comprising the polymorph Form B of Claim 1 and at least one additional component selected from the group consisting of surfactants, solid diluents and 10 liquid diluents, said composition optionally further comprising at least one additional biologically active compound or agent. 3. A composition for protecting an animal from an invertebrate parasitic pest comprising a parasiticidally effective amount of the polymorph Form B of Claim 1 and at least one carrier. 15 4. The composition of Claim 3 in a dosage form for oral administration. 5. A method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of the polymorph Form B of Claim 1. 6. The method of Claim 5 wherein the environment is a plant. 20 7. The method of Claim 5 wherein the environment is an animal.
AU2014262192A 2010-05-27 2014-11-11 Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide Abandoned AU2014262192A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014262192A AU2014262192A1 (en) 2010-05-27 2014-11-11 Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/348,958 2010-05-27
AU2011258621A AU2011258621B2 (en) 2010-05-27 2011-05-19 Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -N- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide
AU2014262192A AU2014262192A1 (en) 2010-05-27 2014-11-11 Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2011258621A Division AU2011258621B2 (en) 2010-05-27 2011-05-19 Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -N- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide

Publications (1)

Publication Number Publication Date
AU2014262192A1 true AU2014262192A1 (en) 2014-11-27

Family

ID=51946430

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014262192A Abandoned AU2014262192A1 (en) 2010-05-27 2014-11-11 Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide

Country Status (1)

Country Link
AU (1) AU2014262192A1 (en)

Similar Documents

Publication Publication Date Title
AU2011258621B2 (en) Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -N- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide
EP2158188B1 (en) Naphthalene isoxazoline invertebrate pest control agents
US9018220B2 (en) Mesoionic pesticides
AU2008308907B2 (en) Naphthalene isoxazoline compounds for control of invertebrate pests
CA2768702C (en) Mixtures of mesoionic pesticides
US20120122680A1 (en) Mesoionic pesticides
CA2684671A1 (en) Isoxazoline insecticides
WO2009051956A2 (en) Pyrazole-substituted isoxazoline insecticides
WO2012087630A1 (en) Pyridine and pyrimidine compounds for controlling invertebrate
WO2012012366A1 (en) Pesticidal 3-(aryloxy)azacycloalkanes
AU2018202270B2 (en) Naphthalene isoxazoline invertebrate pest control agents
RU2575121C2 (en) Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide
AU2014262193A1 (en) Naphthalene isoxazoline compounds for control of invertebrate pests
AU2014262192A1 (en) Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide
AU2013273726A1 (en) Naphthalene isoxazoline invertebrate pest control agents

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application